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4.1G belongs to the membrane-associated band 4.1 protein family, which plays 
important roles in establishing and maintaining the links between transmembrane 
proteins and the cytoskeleton. To date, the expression and functions of 4.1G in the 
central nervous system (CNS) have not been fully elucidated. In the present study, 
expression and biological functions of 4.1G in the rat CNS and in cultured 
oligodendrocyte cell line OLN-93 were investigated. 
4.1G cDNAs were cloned from rat cDNA libraries by using polymerase chain 
reaction. An exclusion of exons encoding the 4.1G spectrin-actin binding domain 
was found. Besides, four other alternative splicing variants that were mainly 
different in the exons encoding 4.1G U3 regions were also cloned. In situ 
hybridization revealed a splicing variants-specific distribution of 4.1G mRNAs in 
CNS (glial localization vs neuronal localization). Specific polyclonal antibodies 
against 4.1G U1 or U3 regions were also generated. Immunoblotting and 
immunoprecipitation revealed rat CNS 4.1G protein isoforms with molecular 
weights ranging from ~80 to ~180 kDa. Immunoperoxidase and 
immunofluorescence double labeling study demonstrated the expression of 4.1G in 
microglia, some oligodendrocytes, and a selected group of neurons in spinal cord.  
In subconfluent OLN-93 cell culture, overexpression of full-length 4.1G and 
C-terminal-domain-deleted 4.1G, but not the four-point-one-erzin-radixin-moesin 
(FERM)-domain-deleted 4.1G, promoted cellular arborization. Whereas in confluent 
 xv
SUMMARY 
cells, endogenous 4.1G was localized to the cytoplasmic periphery together with 
tight junction protein ZO-1, and FERM domain of 4.1G seemed essential for the 
recruitment of the protein to the periphery. Calcium switch experiment demonstrated 
that 4.1G promoted tight junction formation, whereas siRNA knockdown of 
endogenous 4.1G inhibited tight junction formation among confluent OLN-93 cells.  
Together, these results suggest functional roles of 4.1G in cellular arborization 




























1. Oligodendrocytes in the central nervous system 
1.1. Cells in the nervous system 
All mammalian nervous systems are divided into two distinct, yet intervening 
parts: the central nervous system (CNS) including the brain and the spinal cord, and 
the peripheral nervous system (PNS) innervating the rest of the body. Despite the 
anatomical difference between CNS and PNS, both are comprised of two major 
types of cells: neurons and glia. Although neurons exist in the nervous system with 
an extraordinary amount, glia profoundly outnumber neurons approximately by 
ten-fold. In spite of their relatively fewer amount in the nervous system, neurons are 
the main signaling units and function significantly and uniquely to sense the 
environmental alterations, communicate with other neurons, and control the body’s 
responses to the sensation of changes. On the other hand, glia mainly function to 
support, nourish, and insulate neurons to ensure proper and efficient neuronal 
functions. 
Although neurons can be extremely varied in terms of their morphological 
appearance, connections, and neurotransmitter released, a typical neuron bears four 
well defined morphological regions, the soma, the axon, dendrites, and presynaptic 
terminals, each of which contributes uniquely to the neuronal signaling. The soma, 
i.e. the neuron cell body, contains various organelles like most of other types of cells 
and serves as the metabolic center of the neuron. Dendrites are tree-like branches 
extending from the soma and function like antennae of the neuron to receive 
incoming signals from other neurons. An axon also extends from the soma, but 
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conveys signals from the neuron to other neurons. The outgoing signals, also called 
action potentials, are conducted in the axon in a saltatory manner from the initial 
segment towards the terminal arbor of the axon. The axon terminal is specialized to 
form presynaptic terminal, which transforms the electrical pulses into 
neurotransmitter release.  
Based on their different structures and functions, glial cells are classified to 
three major categories: astrocytes, microglia, and myelinating glia (oligodendrocytes 
in CNS and Schwann cells in PNS). Although they are conventionally thought to 
only structurally support neurons, glia are now more appreciated for their 
contribution in information processing in the nervous system. The star-shaped 
astrocytes reside in the space between neurons and essentially regulate the 
concentration of extracellular chemical substances, including ions and 
neurotransmitters, to avoid the potential interference to the proper neuronal signal 
conduction. Besides, astrocytes are also believed to facilitate formation of tight 
junctions between endothelial cells of blood vessels and creating blood-brain-barrier. 
Microglia are generally considered the resident macrophages to provide immune 
defense in the nervous system. Their roles in rest state are unclear so far. However, 
upon nervous system injury or infection, microglia are activated, uptake cell debris 
and infectious pathogens like scavenger cells, and are capable of antigen 
presentation to provoke inflammation reaction to defend against the infection or 
damage. Oligodendrocytes in CNS and Schwann cells in PNS are the myelinating 
glial cells, which wrap the axons in a spiral way with their extending processes thus 
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ensheath the axons. The oligodendrocyte or Schwann cell membrane ensheathing the 
axon is termed as myelin, which prevents the action potential conducted along the 
axon from diffusion. Therefore, myelinating glial cells mainly function to maintain 
the rapid nerve pulse conduction along the axon (Reviewed in Kandel et al, 2001). 
 
1.2. Oligodendrocytes and myelin in CNS 
Oligodendrocytes, the CNS-type of myelinating cells, were first identified by 
Rio Hortega as a distinct type of glia other than astrocytes with metallic 
impregnation techniques. As compared to astrocytes, oligodendrocytes displayed 
much less processes in the materials stained with above mentioned method. Later 
studies found that these cells were of relatively small cell size and dense cytoplasm 
and nucleus. A distinguishing characteristic of oligodendrocytes is that these cells 
extend numerously membranous processes and each process wraps a segment of the 
contacting axon in a spiral manner to form condensed sheath called myelin. 
Originating from the mitotic and migratory precursors, the oligodendrocyte lineage 
progressively develops and differentiates into the mature myelin-forming 
oligodendrocyte. Before the final maturation, these cells undergo distinct 
developmental stages, sequentially including stages of precursor, 
pre-oligodendrocyte, immature oligodendrocyte, non-myelinating mature 
oligodendrocyte, and myelinating mature oligodendrocyte, marked by different 
morphological manifestation, molecular specification, as well as migratory and 
mitotic status (Baumann and Pham-Dinh, 2001).  
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1.2.1. Morphological differentiation during oligodendrocyte lineage progression 
During oligodendrocyte lineage progression, dramatic morphological changes 
take place, gradually progressing from unipolar precursor cells, to bi- or multi- polar 
pre-oligodendrocyte, finally to the myelinating mature oligodendrocytes with 
multiple highly ramified processes, which apparently facilitate their function to 
ensheath around the axons. Changes in cellular morphology are largely mediated by 
the remodeling of intracellular cytoskeletons. Oligodendrocytes contain 
microfilaments and microtubules, but not intermediate filaments.  
 
1.2.1.1 Microfilament-related morphological differentiation 
Microfilaments comprise of polymerized actin subunits and are important in 
cellular process outgrowth by mediating the formation of membrane protrusions. In 
oligodendrogenesis, actin-cytoskeleton is evident to be involved in both cell 
arborization and process elongation through the identification of actin-cytoskeleton 
related proteins, including non-muscle myosin IIB, Juxtanodin, mayven, and etc. For 
example, non-muscle myosin IIB is capable of binding microfilaments and 
concentrated in the leading edges of the processes during early oligodendrogenesis 
(Song et al, 2001). Juxtanodin, an oligodendrocyte-specific filamentous actin 
(F-actin)-binding protein, promotes cellular arborization when exogenously 
expressed in cultured oligodendroglia by inhibiting the depolymerization of F-actin 
in a phosphorylation-dependent manner (Zhang et al, 2005; Meng et al, 2010). 
Mayven, another actin-binding protein, is expressed throughout and up-regulated 
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along the oligodendrocyte differentiation stages (Soltysik-Espanola et al, 1999). 
Overexpressed Mayven not only promotes the extension of processes de novo but 
also helps increase in the length of processes in oligodendrocyte precursor cells 
(Jiang et al, 2005a; Williams et al, 2005). The more recent discovery of 
Mayven-related protein 2 (MRP2) promoting the process elongation of rat 
oligodendrocytes further supports actin-cytoskeleton related morphological 
differentiation in oligodendrocyte lineage progression (Jiang et al, 2007). 
 
1.2.1.2 Microtubule-related morphological differentiation 
Reorganization of microtubules, assembled from α-tubulin and β-tubulin 
heterodimer, during oligodendrocyte differentiation is also required for the 
morphological alteration to fulfill the myelinating function. A list of tubulin-related 
proteins is identified to play crucial roles in regulating this process. For example, 
Tau is a microtubule associated protein frequently implicated in regulating process 
outgrowth in oligodendrocyte (LoPresti et al, 1995; Gotz et al, 2001). 
Overexpression of a Tau deletion mutant alters the Fyn kinase-Tau-microtubule 
interaction cascades and causes a significant decrease in process number and length 
in oligodendroglial cells (Klein et al, 2002). A similar observation is also 
documented after knockdown of Tau by antisense oligonucleotides in 
oligodendrocytes (Gordon et al, 2008). On the other hand, there seems also proteins 
existed to control the morphological differentiation to prevent it from being 
overwhelming.  Overexpression of Sirtuin 2, an oligodendrocyte-specific tubulin 
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deacetylase, resulted in less complex morphology in term of the cellular ramification 
in primary oligodendrocytes (Li et al, 2007).  
The finding that Sirtuin 2 is able to antagonize Juxtanodin effect on promoting 
cellular arborization in cultured oligodendroglia suggests that microfilaments and 
microtubules, as well as the respective associated proteins, work collaboratively to 
mediate and control the morphological differentiation during oligodendrocyte 
lineage progression. Identification of other regulating proteins and unveiling the 
detailed mechanisms as to how they work will be persistent.  
 
1.2.2. Myelination and Myelin  
The main function of an oligodendrocyte in the CNS is to spirally wrap the 
axons with its extended membranous processes, which will later compact into 
multilamellar membrane structure called myelin. The lipid-rich and water-lack 
nature of the myelin lamellae makes it perfect to insulate the axons and results in 
rapid propagation of action potentials along the axon in a saltatory manner. 
Therefore, the electrical signals are conducted in myelinated axons more rapidly. 
 Each oligodendrocyte is able to myelinate several surrounding axons with its 
numerous processes. On the other hand, a single axon is ensheathed by more than 
one oligodendrocyte, each of which wraps one segment of the axon. Periodic axonal 
membrane patches, called node of Ranvier, which is not covered by myelin sheath, 
separate the myelin segments. Individual myelin segment in between two nodes of 
Ranvier is termed internode. Each myelin internode ends with less compact 
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oligodendrocyte cytoplasm-containing membrane loops, which conventionally called 
paranodal loops. The more recent identification of specific juxtanodin localization to 
the few lateral terminal loops might define them to be functionally different 
juxtanodes. 
As described above, a myelin internode can be divided into distinctive regions 
and/or compartments, including the compact myelin, juxtaparanodal region, 
paranodal region, and juxtanodal region (Fig 1-1). Each region shows characteristic 
structures and gene expression profile, which in turn imply different functionalities 
(Baumann and Pham-Dinh, 2001).  
 
Figure 1-1. Domains of myelinated axon in the CNS.  
An electron micrograph (A) and a schematic representation (B) show domains of 
myelinated axon in the CNS. a, axon; Jn, juxtanode; JP, juxtaparanode; N, node of 
Ranvier; PN, paranode. Scale bar: 0.3 μm. Image is cited from Zhang et al (2005). 
 
The compact myelin is organized by apposing the outer surface of adjacent 
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oligodendrocyte membrane together, and apposing the inner surface of the 
ensheathing lamella followed extruding the cytoplasmic contents. Under electron 
microscope, the appositions of the inner surfaces appear as electron-dense major 
dense lines, whereas the appositions of the outer surfaces appear as electron-light 
double intraperiodic lines (Reviewed in Kandel et al, 2001). There are specialized 
expression of myelin proteins which are found to be essential for myelin compaction, 
structure sustaining, and proper function. For example, myelin basic protein (MBP), 
which constitutes up to 30% of CNS myelin protein content, is important in CNS 
myelin compaction by anchoring the cytoplasmic surface of the two apposing 
bilayers as the shiverer mutant mice with a large deletion of MBP gene display 
abnormal myelin with absence of major dense lines (Wood et al, 1977; Boggs and 
Moscarello, 1978; Matthieu et al, 1980). Proteolipid proteins (PLP, and its isoform 
DM20), the most prominent CNS myelin protein, are believed to stabilize the 
membrane junctions between the myelin lamellae after myelin compaction (Boison 
et al, 1995). In PLP-null mice, although myelination and myelin compaction proceed 
as normal, the condensation of the double intraperiodic lines and the physical 
instability are observed, suggest functional roles of PLP/DM20 in stabilizing myelin 
structure (Rosenbluth et al, 1996; Klugmann et al, 1997; Rosenbluth et al, 2006). 
Oligodendrocyte-specific protein (OSP), the third most abundant CNS myelin 
protein after PLP/DM20 and MBP, mediates the formation of tight junction strands 
between adjacent myelin lamellae (Morita et al, 1999c). Depletion of OSP seemingly 
does not affect myelination and the stability of myelin, the conduction of action 
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potentials along the axons, however, is disturbed, suggesting that OSP maintains the 
essential function of the myelin sheath (Gow et al, 1999).  
Myelin at juxtanode and paranode is less compact and contains small amount of 
oligodendrocyte cytoplasm. They appear as regular membrane loops making contact 
with the juxtanodal and paranodal axolemma (axon membrane). The molecular 
interaction between the paranodal membrane of oligodendrocytes and the axolemma 
is evident. For example, neurofascin 155, an oligodendrocyte integral membrane 
protein bind to contactin associated protein (Caspr) integrated in the axolemma, 
serving to maintain the neuro-glial interaction and to fence the adjacent node of 
Ranvier to restrict the free diffusion of ion channels (Charles et al, 2002). Despite of 
the morphological similarity, juxtanode might be defined as a region different from 
the paranode. For example, juxtanodin is mainly expressed in the juxtanodes but not 
the paranode, suggesting specific gene expression profile in this region (Zhang et al, 
2005). While paranodes are likely to facilitate the interaction between 
oligodendrocyte and axon, juxtanodes are presumably to initiate the node of Ranvier.  
 
2. Tight junctions 
2.1. Types of cell junctions 
Cells are small, deformable and often motile building elements of tissues in 
almost all organisms. Within various tissues, cells are commonly associated to each 
other or to the extracellular matrix, so that they are held together to form the 
multicellular assemblies with strength and proper functions. The specialized regions 
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at cell-cell and cell-matrix contact are referred to as cell junctions, which exist in 
almost every tissue and are especially enriched in epithelia.  
There are three categories of cell junctions according to their specialized and 
distinctive functions: 1) Communicating junctions provide channels for the moving 
of chemical or electrical signals between connected cells; 2) Anchoring junctions 
link cells along with their cytoskeletons to their neighboring cells or to the 
extracellular matrix; and 3) Occluding junctions seal cells together to form a barrier 
preventing leakage of molecules across the barrier (Table 1-1). 
 
Table 1-1: A functional classification of cell junctions 
Communicating junctions 
 1. gap junctions 
2. chemical synapses 
Anchoring junctions 
 1. adherens junctions (cell-cell junctions) 
2. desmosomes (cell-cell junctions) 
3. focal adhesions (cell-matrix junctions) 
4. hemidesmosomes (cell-matrix junctions) 
Occluding junctions 
 1. tight junctions (vertebrates) 




In multicellular organism, all cellular activities of one individual cell must be 
coordinated with those of other cells. Several types of communications have been 
evolved such as endocrine and neural transmission mechanisms in long-range. In 
short range, more direct communications between neighboring cells can be mediated 
by communicating junctions such as gap junctions and chemical synapses. Except 
for some fully differentiated cells like blood cells, most cells in normal tissues 
communicate with their neighboring cells through gap junctions. The basic structural 
units of gap junctions are the connexons (the channels), which are assembled by the 
principal gap junctional proteins, connexins. Six connexins come together to make a 
connnexon. Connexons of apposing plasma membrane of neighboring cells assemble 
channels for the passage of electrical signals or metabolites (Finbow and Pitts, 1993). 
In the nervous system, neurons can signal to neurons or to other non-neuronal cells 
through another type of communicating junctions, chemical synapses, which pass the 
signals (also called neurotransmitters) from a presynaptic cell to a postsynaptic cell. 
 As the term itself implicated, anchoring junctions tether the intracellular 
cytoskeleton to the extracellular matrix or to the cytoskeleton of neighboring cells. 
There are two functional forms of anchoring junctions. One form holds the adjacent 
cells together by cadherin family proteins. This type of anchoring junction includes 
adherens junctions and desmosome. The other form includes focal adhesions and 
hemidesmosomes which tether the cells to the extracellular matrix by integrin family 
proteins. Adherens junctions are assembled by the cadherins, of which the 
extracellular domain binds to that of the opposing cadherins and the intracellular 
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domain is linked to the cortical actin filaments beneath the plasma membrane by 
some anchoring proteins such as catenins and α-actinin (Harris and Tepass, 2010). 
On the other hand, desmosomes are buttonlike points formed by desmosomal 
cadherin proteins between interacting cells. They not only rivet the two cells together, 
but also serve as anchoring sites for the intermediate filaments inside the cells. Focal 
adhesions hold the cells on the extracellular matrix via integrins which connect actin 
cytoskeleton inside the cells (Yin and Green, 2004). Hemidesmosomes 
morphologically resemble desmosomes and also connect to the intermediate 
filaments. However, they rivet the cells to the basal lamina instead of their neighbors 
(Zhang and Labouesse, 2010).  
Occluding junctions seal adjacent cells together to serve as selective 
permeability barriers to maintain asymmetrical chemical compositions between two 
sides and also divided the cells themselves into distinctive membrane domains with 
quite different molecular specifications (so-called fence function). Tight junctions 
serve these functions in most vertebrates, whereas, in invertebrates, septate junctions 
are the main occluding junctions. The molecular architecture of tight junctions, the 
signalling to and from tight junction, as well as the functional relevance of tight 
junctions in nervous system will be briefly reviewed in the following section 
(Reviewed in Alberts et al, 2002) 
 
2.2. Tight junctions 
Over a century ago, scientists found an intercellular thickening between 
 13
INTRODUCTION 
polarized epithelial cells and they termed it as the terminal bar. Only with the 
advance of electron microscope in early 1960s, Farquhar and Palade (1963) first 
morphologically described the intercellular junctions, which limited the paracellular 
movement of some tracer molecules, thus termed them as tight junctions or zonula 
occludens. In conventional electron micrographs, tight junctions appear as 
membrane appositions of neighboring cell fusing together (sometimes also referred 
to as kissing points). In freeze-fracture electron micrographs, the tight junctions look 
like continuous and branching networks of strands of particles, surrounding the 
apical regions of the lateral membrane of the epithelial cells (Pinto da and Kachar, 
1982; Gumbiner, 1987; Shin et al, 2006). Studies have revealed that the particle 
strands are the core structures of tight junctions, which compose of transmembrane 
proteins binding to the partners in the opposing membrane of neighboring cells and 
thus sealing the space between cells (Tsukita et al, 1999; Tsukita and Furuse, 2000; 
Chiba et al, 2008b; Furuse, 2010c). Besides, more and more proteins have been 
identified to be adaptor proteins which link the transmembrane core proteins with the 
cytoplasmic molecules and cytoskeleton to form complex structures (Shin et al, 2006; 
Fanning and Anderson, 2009). 
Conventionally, tight junctions are mainly considered to serve as intercellular 
selective barriers, to create extracellular compartments with distinguished chemical 
compositions, and molecular fences, to separate membrane domains with uneven 
distribution of lipids and protein molecules (Stevenson et al, 1988; Schneeberger and 
Lynch, 1992). However, recently emerging evidences also point tight junctions to be 
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bidirectional signalling centers. Signals sending from and coming to tight junctions 
would coordinate various cellular functions such as polarity specification, 
proliferation, and differentiation (Matter and Balda, 2003; Kohler and Zahraoui, 
2005; Balda and Matter, 2009).  
 
2.2.1. Molecular architecture of tight junctions 
With extensive investigation, many proteins have been identified as tight 
junction proteins to-date, although some of these proteins still remain functionally 
unclear and serve only as markers. Among these numerous proteins, transmembrane 
proteins belong to apposing membrane bind each and intracellularly interact with the 
peripheral membrane proteins to form a complex protein network (Chiba et al, 2008; 
Furuse, 2010). There are also intracellular scaffolding proteins, which bind the 
transmembrane proteins and/or peripheral membrane proteins and link them to the 
actin cytoskeleton (Furuse, 2010). Besides, signalling proteins also bind to the 
protein network and convey the signals from and to the tight junction complex 






















Figure 1-2. Molecular architectures of tight junction. 
Schematic representation of membrane-integral and intracellular molecules and their 
interactions in tight junction. 
 
2.2.1.1. Transmembrane proteins of tight junctions 
Transmembrane proteins are essential to the tight junction complex as they 
form the very basis of the complex by binding each other across the junction and 
sealing the adjacent membrane together. There are, so far, three major families of 
transmembrane proteins serving as tight junction core structure. They are, namely, 
occludin, claudins, and junctional adhesion molecules (JAMs).  
Occludin. Occludin is the first identified transmembrane protein at tight 
junctions (Furuse et al, 1993). Topological study of occludin revealed two 
intracellular domains, four transmembrane domains, and two extracellular loops 
(Feldman et al, 2005). The transmembrane domains and the extracellular loops are 
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believed to be responsible for the barrier function and particularly, the second 
extracellular loop plays important roles in correct incorporation of occludin to the 
tight junction (Wong and Gumbiner, 1997). On the other hand, inside the cell, 
C-terminus of occludin, which contains about 250 amino acids, mediates the 
interaction of occludin with protein zonula occludens (ZO)-1 and ZO-2 (Furuse et al, 
1994; Chen et al, 1997; Matter and Balda, 1998). Occludin is also linked to 
intracellular actin cytoskeleton and transmembrane JAMs through its interaction 
with ZO proteins indirectly (Fanning et al, 1998). The functional importance of 
occludin was illustrated by several lines of evidences. Overexpression of occludin 
with truncation in its C-terminus in MDCKII cells increased the paracellular 
permeability, while overexpression of occludin in fibroblasts without endogenous 
occluding enhanced intercellular adhesion (Balda et al, 1996; Van Itallie and 
Anderson, 1997). However, it is surprising to find that the morphology and barrier 
function of tight junction are not affected in the intestinal epithelium of occludin 
knockout mice, although in gastric epithelial cells the histological abnormalities 
were observed (Saitou et al, 2000). This suggested that the functions of occludin 
might have been compensated by other integral membrane tight junction proteins. 
Claudins. Claudins are also a family of integral membrane proteins which 
constitute the intercellular strands of tight junctions. Since the first identification of 
claudin-1 and -2 by Furuse et al. from the fractionated chicken liver, more than 20 
claudin family proteins have been documented (Furuse et al, 1998a; Furuse et al, 
1998c; Tsukita et al, 2001). Topologically, claudins resemble occludin as they are 
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similarly composed of two intracellular domains, four transmembrane domains, and 
two extracellular domains (Morita et al, 1999a). Nevertheless, claudins share almost 
no sequence homogeneity with occludin (Furuse et al, 1998b). In each tight junction 
strand or between strands, claudins interact with each other in both homotypical and 
heterotypical manners (Furuse et al, 1999). The C-termini of Claudins are conserved 
throughout the family and consist of several postsynaptic density/discs large/zonula 
occludens (PDZ)-binding motifs, via which claudins directly bind some peripheral 
membrane proteins containing PDZ-domains, such as ZOs (Itoh et al, 1999b), 
multi-PDZ domain protein 1 (MUPP-1) (Hamazaki et al, 2002), and protein 
associated with Lin seven 1 (PALS1)-associated tight junctions protein (PATJ) (Roh 
et al, 2002b). 
Claudins play pivotal roles in regulating the barrier functions of tight junction, 
although in different cells this regulation may be due to the coordination of different 
combinations of claudin isoforms. In claudin-1 knockout mice the epidermal barrier 
function was deficient, causing death of the animals from dehydration within one 
day of birth (Furuse et al, 2002). Claudin-4 expression in epithelia increased 
transepithelial resistance (TER) by decreasing sodium permeability (Furuse et al, 
2001). Furthermore, claudin-16 mutations probably cause human disease syndromes 
with impaired paracellular magnesium and calcium permeability (Simon et al, 1999; 
Hou et al, 2005). Besides, OSP/Claudin-11 plays crucial roles in the proliferation 
and differentiation of oligodendrocyte lineage (Morita et al, 1999b; Tiwari-Woodruff 
et al, 2001). Research findings have identified potential regulation of claudins barrier 
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function by phosphorylation with several protein kinases (Fujibe et al, 2004; Soma et 
al, 2004; D'Souza et al, 2005; Tanaka et al, 2005; Ikari et al, 2006a). 
Junctional adhesion molecules. JAMs are mainly epithelia-expressed 
immunoglobulin superfamily proteins, although the expression of JAMs in other 
cells types like leukocytes, platelets, and endothelial cells is also evident (Bazzoni, 
2003). So far, four JAM proteins have been found, including JAM-A, JAM-B, 
JAM-C, and JAM4/JAML (Mandell and Parkos, 2005). JAMs are structurally 
different from occludin and claudin, consisting of two extracellular Ig-like motifs, a 
single transmembrane region, and a cytoplasmic tail (Kostrewa et al, 2001). There 
exist dimerization motifs in the extracellular domain of JAMs, implying that the 
extracellular domain is responsible for the homophilic interaction between JAMs 
(Bazzoni et al, 2000a). With the only exception of JAM4/JAML, all other JAMs 
contain C-terminal PDZ-binding motif, which probably participate in the interactions 
with several peripheral membrane proteins such as ZO-1, multi-PDZ domain protein 
1 (MUPP1), etc (Bazzoni et al, 2000b; Ebnet et al, 2001; Itoh et al, 2001; Ebnet et al, 
2003). The involvement of JAMs in the tight junction assembly and function is also 
demonstrated. For example, when JAM protein function was blocked, a decrease in 
TER and defects in barrier function were observed in epithelia (Liu et al, 2000). 
Although the JAM-1 homodimer formation strongly implies the regulation of tight 
junctions formation by JAM-1, a more direct association between JAMs function 
and tight junction assembly has not been established so far (Mandell et al, 2004).  
Tricellulin. Tricellulin is a relatively new transmembrane tight junction protein 
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identified by Ikenouchi et al in 2005. It is a special type of integral membrane tight 
junction protein since it mainly mediates the tricellular tight junction assembly, i.e. 
the tight junction formation at sites where three cells join together, as the name itself 
implies (Ikenouchi et al, 2005). Several alternative splicing isoform of tricellulin 
have been reported (Riazuddin et al, 2006a). Topologically it resembles occludin as 
it is also a tetraspan transmembrane protein consisting of two intracellular domains, 
four transmembrane regions, and two extracellular loops. Tricellulin is able to 
homophilically bind each other or heterophilically interact with occludin and these 
interactions form the basis of tricellular tight junction (Westphal et al, 2010). The 
importance of tricellulin in assembly of tricellular tight junctions was demonstrated 
by the decreasing in TER and disrupts in barrier function following the treatment 
with RNAi to tricellulin (Ikenouchi et al, 2005). Moreover, it was found that 
tricellulin was responsible for assembling tricellular tight junctions at cochlear and 
vestibular epithelia and that the recessive mutations of tricellulin resulted in 
nonsyndromic deafness (Riazuddin et al, 2006b). 
 
2.2.1.2. Peripheral membrane proteins of tight junctions 
While the transmembrane tight junction proteins are essential in forming the 
structural basis of tight junction strands and mediating the barrier functions, the 
peripheral membrane tight junction proteins are also not dispensable as they not only 
organize the transmembrane proteins in the membrane by establishing the link 
between the transmembrane proteins and the cytoskeleton but also initiate cell 
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signaling events (Matter and Balda, 2003; Anderson and Van Itallie, 2009).  
Zonula occludens. To-date, three isoforms of ZOs, namely ZO-1, ZO-2, and 
ZO-3, have been documented. They belong to the membrane-associated guanylate 
kinase (MAGUK) family of proteins. These protein are very conserved in terms of 
their domain structure, with one or more PDZ domains, an Src homology (SH) 3 
domain, and a guanylate kinase (GUK) domain (Stevenson et al, 1986; Jesaitis and 
Goodenough, 1994; Haskins et al, 1998). Among all ZO proteins, the N-termini 
mainly mediate the interactions with transmembrane tight junction protein. For 
example, it is believed that the first PDZ-domain binds claudins, the third 
PDZ-domain binds to JAMs, and the GUK domain interact with occludin and 
tricellulin (Furuse et al, 1994; Fanning et al, 1998; Cordenonsi et al, 1999; Itoh et al, 
1999; Bazzoni et al, 2000; Umeda et al, 2006). As scaffolding proteins, on one hand, 
ZOs bind several integral membrane tight junction proteins via the aforementioned 
interactions; on the other hand, ZOs also interact with other cytoplasmic proteins. 
For example, ZO-1 is capable of binding ZO-2 and ZO-3 through the second 
PDZ-domain (Wittchen et al, 1999). ZOs are also reported to bind to F-actin and 
4.1R, thus link the tight junction to the intracellular actin cytoskeleton(Fanning et al, 
1998; Mattagajasingh et al, 2000). Taken together, all these findings suggest 
important functional roles of ZOs in tight junction assembly not only in directly 
interacting with transmembrane proteins, but also in integrating transmembrane 
proteins and cytoplasmic proteins, as well as cytoskeleton, to form complex arrays of 
proteins at tight junctions. However, until very recently, the mechanisms, via which 
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ZOs regulate the assembly of tight junction, are still largely unclear, although a 
calcium dependent signalling pathway has been proposed (Larina and Thorn, 2005). 
Cingulin. Cingulin, initially identified by Citi et al as a peripheral membrane 
protein in avian intestinal brush border cells, is a 140 kD protein which has 
subsequently been localized to the cytoplasmic surface of epithelial tight junctions 
(Citi et al, 1988; Citi et al, 1989). Topologically, Cingulin consists of globular head 
and tail domains and a central α-helical rod domain (Cordenonsi et al, 1999). 
Cingulin is able to form coiled-coil parallel dimers via the central α-helical domain 
(Citi et al, 2000). The involvement of cingulin in tight junction assembly is 
demonstrated by the direct association of cingulin with both transmembrane JAM-A 
and ZOs (Cordenonsi et al, 1999; Bazzoni et al, 2000; D'Atri et al, 2002). In addition, 
cingulin is also capable of cosedimentating with F-actin in vitro, implying a 
physiological association in vivo (D'Atri and Citi, 2001). These studies demonstrate 
cingulin as a peripheral membrane component of tight junction complex and may be 
involved in cross-linking tight junction with actin cytoskeleton. However, the fact 
that disruption of cingulin gene expression does not prevent the tight junction 
formation somehow suggests that the function of cingulin may be spared and would 
be compensated by other tight junction proteins (Guillemot et al, 2004).  
 ZO-1-associated nuclei acid-binding protein (ZONAB). ZONAB is an 
intracellular ZO-1 binding partner. However, unlike other peripheral membrane 
proteins, it not only localizes to the tight junction, but also to the nucleus (Balda and 
Matter, 2000). Despite the special localization, the function of ZONAB also appears 
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unique. In the condition of low cell density when the expression level of ZO-1 is low, 
ZONAB is free from the association with ZO-1, translocated to the nucleus, and 
regulate gene expression controlling cell cycles. On the other hand, at high cell 
density, ZONAB is largely sequestered by ZO-1 at the tight junctions and is thus 
incapable of regulating gene expression (Balda and Matter, 2000b; Balda et al, 
2003b). Therefore, ZONAB apparently serves as a sensor of cell density to control 
cell proliferation and gene expression. Despite the direct association between ZO-1 
and ZONAB, little is known about whether or how ZONAB affects tight junction 
formation. 
 
2.2.1.3. Polarity protein complexes. 
Polarity complexes are evolutionarily conserved multiple protein complexes 
which are involved in epithelial cell polarization, i.e. establishment and maintenance 
of the apico-basolateral polarity. Recent findings suggest that some of these 
complexes are targeted to the tight junction and actively guide tight junction 
assembly. 
CRB3/PALS1/PATJ complex. The mammalian Crumbs (CRBs) are 
transmembrane proteins. So far, three CRB isoforms, CRB1, CRB2, and CRBs, have 
been identified with similar topological structure containing an extracellular domain, 
a transmembrane region, and an intracellular domain bearing PDZ-binding and 
FERM-binding motifs. Among three CRB proteins, CRB3 prominently localizes to 
the tight junction, where it bind protein associated with Lin seven 1 (PALS1) via the 
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intracellular PDZ-binding motif. PALS1 belongs to MAGUK proteins and consists 
two L27 domains, a PDZ domain, an SH3 domain, a Band-4.1-binding domain, and 
a GUK domain. Through one of the L27 domain, PALS1 in turn interacts with 
PALS-associated tight junction protein (PATJ), which is a multiple 
PDZ-domain-containing protein at tight junctions (Kamberov et al, 2000). Direct 
interactions between PATJ and ZO3 and claudin-1 have been elucidated to be 
mediated by the sixth and eighth PDZ domain respectively (Roh et al, 2002). The 
importance of CRB3 complex in tight junction formation has been widely studied. 
For example, overexpression of CRB3 in MCF10A cells, which lacked the 
endogenous CRB3 and did not form tight junctions, was sufficient to induce 
functional tight junction formation (Fogg et al, 2005). In another study, silencing 
PALS1 expression with RNA interfering inhibited tight junction formation in 
mammalian epithelial cells (van Rossum et al, 2006). Furthermore, PATJ also has a 
crucial role in tight junction integrity as disruption of tight junctions was observed 
when PATJ was sequestered from the junction by adenovirus E4-ORF1 (Latorre et al, 
2005).  
Par3/Par6/aPKC complex. Partition defective (Par) 3 and Par6 were first 
identified in C. elegans as PDZ-containing protein (Kemphues et al, 1988; Hung and 
Kemphues, 1999). In mammalian epithelial cells, mammalian homologues Par3 and 
Par6 interact with each other as well as with atypical protein kinase C (aPKC) to 
form the Par3/Par6/aPKC complex, which localizes to the tight junctions (Lin et al, 
2000; Joberty et al, 2000a). It has been illustrated that Par3 may serve as a 
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scaffolding protein to target the Par3/Par6/aPKC complex to the tight junction by 
interacting with the transmembrane JAM (Ebnet et al, 2001; Ebnet et al, 2003). The 
interaction between Par3 and aPKC appears to promote tight junction assembly in 
epithelial cells (Joberty et al, 2000b). In another study, Par3 was found to interact 
with T lymphoma invasion and metastasis (Tiam1) and inhibit Rac activation 
mediated by Tiam1 (Mertens et al, 2005). This interaction consequently resulted in 
the promotion of tight junction formation (Mertens et al, 2006; Pegtel et al, 2007).  
 
2.2.2. Signalling to and from tight junctions 
For quite a long period of time, tight junctions are considered only to serve as 
selective permeability barriers to separate different tissue compartments and as 
molecular fences to maintain polarized membrane molecular compositions. However, 
recent growing evidence has shed light on the notion that tight junctions function as 
bidirectional signalling centers as well. On the one hand, signals coming from the 
inside of the cells are transduced to guide the adequate assembly and proper function 
of tight junctions; on the other hand, signals conveyed from the tight junctions to the 
interior of the cells in turn regulate gene expression and cell proliferation and 
differentiation (Anderson and Van Itallie, 1999; Matter and Balda, 2003b; Balda and 
Matter, 2009a). 
Signals transmitted to the tight junctions generally fall into two categories: to 
regulate the assembly and disassembly of tight junction and to modulate the selective 
barrier function of tight junction, although these two categories of signals are often 
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overlapped. In a model of tight junction assembly proposed by Matter and Balda, the 
event is initiated by establishing E-cadherin dependent intercellular adhesion, 
followed by the formation of a primordial junction which contains both adherens 
junction and tight junction components, and finalized by maturing of distinct 
adherens junction and tight junction (Matter and Balda, 2003). Several signalling 
proteins have been found to stimulate tight junction assembly in this process, 
although sometimes the signalling events are ambiguous due to variations in the 
signal strength, cellular signalling environment, as well as the interplays of other 
signaling events. For example, protein kinase A (PKA) activation was found to 
prevent the disassembly of tight junctions after E-cadherin was neutralized by 
antibody (Behrens et al, 1985). Recent findings suggest that PKA-mediated 
phosphorylation on tight junction components might regulate tight junction assembly 
and disassembly (Kohler et al, 2004; Ikari et al, 2006; Ikari et al, 2008). Guanine 
nucleotide-binding proteins (G proteins), another signalling protein family, are 
implied in tight junction formation signaling event as well. Inactivation of the 
inhibitory G proteins (Gi) promoted the tight junction formation (Fukuhara et al, 
2003). As previously described, Par3/Par6/aPKC complex is also an essential 
signalling complex which is believed to integrate other signalling molecules such as 
cdc42 and is essential for correctly positioning in the late maturation of functional 
tight junctions. Besides, signals from the interior of the cell also modulate the 
paracellular permeability of tight junction. For instance, the migration of 
lymphocytes across the blood vessels was inhibited when Rho-family GTPases in 
 26
INTRODUCTION 
brain endothelial cells were inactivated by C3 transferase (Adamson et al, 1999). In 
another study, when RhoA was activated by transfection of a G-protein coupled 
prostaglandin receptor in MDCK cells, the ionic permeability was reduced as 
indicated by an increased TER (Hasegawa et al, 1999). These seemingly 
contradictory observations might suggest that different cell types employ different 
set of signalling machinery to regulate the tight junction dynamics.  
Signals conveyed from tight junctions to the interior of cells mainly regulate 
gene expression and cell proliferation and differentiation. These signalling events are 
almost exclusively mediated by several peripheral tight junction proteins, which 
have dual localizations to both tight junction plaques and nucleus, including ZONAB, 
cdk4, symplekin, huASH1, and ubinuclein (Matter and Balda, 2007). ZONAB 
controls the expression of the growth factor coreceptor erb2 and cell cycle regulators 
such as cyclin D1 and PCNA (Sourisseau et al, 2006). Sequestration of ZONAB to 
tight junction by interaction between ZONAB and SH3 domain of ZO-1 occurs at 
condition of high cell density and this sequestration in turn repress ZONAB 
controlled gene expression (Balda and Matter, 2000). Furthermore, ZONAB is also 
capable of promoting cell proliferation through binding cdk4 and translocating to 
nucleus (Balda et al, 2003). The sequestration of ZONAB at tight junctions 
eventually causes a reduced level of nuclear cdk4 and inhibits the ZONAB-cdk4 
promoted cell proliferation. Symplekin, a periphery tight junction protein, is part of 
the machinery that controls 3’-end processing of pre-mRNA and polyadenylation. 
Interaction between Symplekin and ZONAB was illustrated by a ZONAB-dependent 
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reduction in expression of cyclin D1 and cell proliferation when symplekin was 
depleted by RNAi (Kavanagh et al, 2006). On the other hand, huASH1 and 
ubinuclein are reported to remodel chromatin and regulate gene expression (Aho et 
al, 2000; Nakamura et al, 2000; Aho et al, 2009).  
 
2.3. Cell junctions in myelin structure 
As introduced in section 1, myelin membrane is divided into two areas, the 
compact myelin regions and the non-compact myelin regions, with obviously 
structural and biochemical distinctions. Furthermore, the non-compact myelin 
regions again are organized into several regions with specialized structural 
characteristics and distinct biochemical compositions. In myelinating 
oligodendrocytes in CNS, the non-compact regions consist of paranodal loops, 
juxtanodal loops, and inner and outer mesaxons; whereas in myelinating Schwann 
cells in PNS, the non-compact myelin regions are divided into paranodal loops, 
Schmidt-Lanterman incisures, nodal microvilli, and the inner and outer mesaxons. It 
is intriguing to find that several types of cell junctions scatter in different 
compartments of myelin membrane in both CNS and PNS. However, unlike cell 
junctions in other cells, the junctions detected in myelin membrane are almost all 
formed between adjacent membrane layers of the same myelinating cells. Therefore, 
they are alternatively named as autotypic cell junctions (Spiegel and Peles, 2002). 
Although the exploration of the mechanisms as to how these different myelin 
compartments are originated and organized is still ongoing, the various cell junctions 
 28
INTRODUCTION 
detected in these regions apparently play important roles in maintaining structural 
and biochemical distinctions and in regulating the myelin function as an electrical 
insulator.  
 
Figure 1-3. Cellular junctions in myelin and myelinated axon.  
Schematic representation of known junctional structures in CNS myelin (A and B) 
and PNS myelin (C; cited from Poliak et al, 2002).  
 
2.3.1. Cell junctions in myelin membrane. 
So far, adherens junctions are mainly identified in PNS myelin at paranodal 
loops, Schmidt-Lanterman incisures, as well as the inner and outer mesaxons. 
Similar to the structure of adherens junctions described previously, adherens 
junctions in PNS myelin are also formed by a cadherin family protein, E-cadherin, 
which is connected to actin filaments indirectly by interacting with a cytoplasmic 
adaptor protein β-catenin (Fannon et al, 1995). These junctions may be formed to 
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stabilize the myelin structures during myelination process. In line with this notion, it 
was found that E-cadherin function is essential for the maintenance of 
Schmidt-Lanterman incisures in myelinating Schwann cells, mediated by the 
recruitment of p120/catenin to the paranodal membrane (Tricaud et al, 2005). 
Specific depletion of p120/catenin did not only destabilize the incisures but also 
result in a marked decrease in the thickness of the myelin sheath (Perrin-Tricaud et al, 
2007).  
In the PNS, tight junctions are not uncommon and they are frequently found in 
the inner and outer mesaxons, paranodal loops and the Schmidt-Lanterman incisures. 
A bunch of tight junction proteins, which are found in epithelial tight junctions 
including both integral membrane proteins such as claudin-1, claudin-2, claudin-5 
and MUPP1 and peripheral scaffolding proteins such as PATJ, ZO-1, ZO-2 and Par3, 
are also present in the tight junctions of myelinating Schwann cells in PNS (Poliak et 
al, 2002). In contrast, tight junctions are only present at the radial component of 
CNS myelin as a series of radially arranged interlamellar strands which cross the 
whole thickness of the compact myelin in CNS (Dermietzel, 1974; Schnapp and 
Mugnaini, 1976; Dermietzel and Kroczek, 1980). So far the only identified tight 
junction protein in CNS is claudin-11, which is alternatively called oligodendrocyte 
specific protein (OSP) (Morita et al, 1999c). The functions of tight junctions in 
myelinating glial cells are not fully elucidated yet. In mice lacking claudin-11/OSP, 
the myelination, myelin ultrastructure, as well as the myelin stability appeared 
normal except that the radial component is absent as compared with the wildtype 
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mice. However, the nerve conduction, especially that of the small myelinated axons, 
is slow (Gow et al, 1999). It is proposed that tight junctions probably potentiate the 
insulative property of CNS myelin sheath by generating electrically tight barriers to 
prevent diffusion from the outer and inner mesaxons (Devaux and Gow, 2008).  
 
2.3.2. Cell junctions at axoglial interaction site 
Axoglial junctions, which are more commonly named as paranodal junctions or 
septate-like junctions, are the orthologues of invertebrate septate junctions 
(Rosenbluth, 1976; Rosenbluth, 1978). They are formed between the axolemma and 
the paranodal loops of myelinating oligodendrocytes in CNS or Schwann cells in 
PNS by adhesion complex consisting neurofascin 155 at the glial side and contactin 
and contactin associated protein (Caspr) at the axonal side (Einheber et al, 1997; 
Peles et al, 1997a; Peles et al, 1997b; Charles et al, 2002). The junctional complexes 
are clustered at the paranodal regions by 4.1B, which crosslinks the complexes to the 
actin cytoskeleton at the axon (Denisenko-Nehrbass et al, 2003). These junctions not 
only structurally connect the membrane of myelinating glial cells to the axon, but 
also restrict the diffuse of membrane molecules, especially the channel proteins, at 
both sides of the junctions, thus maintain the specialized protein compositions at 
node of Ranvier and juxtaparanodes (Horresh et al, 2010). 
 
3. Protein 4.1 superfamily 
3.1. The biochemistry of protein 4.1 superfamily 
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Protein 4.1 superfamily is loosely defined as proteins contain a conserved 
Four-point-one/Ezrin/Radixin/Moesin (FERM) domain at their N-termini. The term 
FERM is coined after the identification of first few members including erythroid 
protein 4.1, or 4.1R, ezrin, radixin, and moesin. Therefore, this protein family is 
alternatively named as FERM superfamily. Since the identification of the first few 
members, this family has largely expanded to include more than 40 proteins. Based 
on their sequence homogeneity and domain structures, these proteins are generally 
subdivided into several families, including ERM proteins, protein 4.1 molecules, and 
protein tyrosine phosphatase (PTPH) proteins, although there are still other members 
not clearly classified. Proteins of this superfamily are evolutionarily conserved, as 
almost all members expressed in mammalian cells could be matched to their 
Drosophila orthologues with only very few exceptions (Diakowski et al, 2006).  
 
3.1.1. The ERM family 
The Ezrin/Radixin/Moesin (ERM) proteins represent another group of proteins 
of high sequencing homogeneity in protein 4.1 superfamily.  In vertebrates, ezrin, 
radixin, and moesin constitute “classic” ERM proteins, although other proteins, 
including merlin in Schwann cells and juxtanodin/ermin in CNS oligodendrocytes 
are also considered as ERM-like proteins (Sato et al, 1992; Haase et al, 1994). All 
ERMs have a very similar domain structure, comprising an N-terminal FERM 
domain, a central α-helical domain, and a C-terminal actin-binding domain (ABD). 
FERM domain of all ERMs contains 3 lobes with unique membrane protein binding 
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site(s) and form a clover-leaf-like assembly. The central domain, containing about 
150 amino acid residues, is predicted to be of high α-helices and prone to form a 
coiled coil structure. The C-terminal ABD is capable of binding filamentous actin 
(F-actin) (Bretscher et al, 2000). 
A characteristic structural feature of ERMs is that, in a dormant state, their 
N-terminal FERM domain binds tightly to their C-terminal ABD. The self-masking 
renders them unable to bind F-actin through the ABD in the C-terminus. The 
discovery, that a conserved Threonine in ABD of all ERMs (Thr576 in ezrin, Thr564 
in radixin, and Thr558 in moesin) could be phosphorylated and lead to ERM 
activation, gives an insight into the molecular mechanisms regulating ERM activities 
(Ivetic and Ridley, 2004). One credible proposal is that the ERMs are first recruited 
to plasma membrane regions of high PIP2 contents, then their conserved Thr site is 
phosphorylated by various types of kinases, and the phosphorylation loosens the 
self-association between FERM and ABD and results in the activation of ERMs.   
 
3.1.2. The protein 4.1 family 
3.1.2.1. Domain structures of protein 4.1 molecules 
As mentioned above, 4.1R is the first protein 4.1 family member identified as 
an erythrocyte membrane protein (Yu and Steck, 1975). More than two decades ever 
since then, it successively came to the identification of 4.1G, 4.1N, 4.1B, and 4.1O, 
although some controversial opinions are still arguing whether 4.1O is a “true” 4.1 
protein or not (Parra et al, 1998; Walensky et al, 1999; Parra et al, 2000; Ni et al, 
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2003). With the exception of 4.1O, 4.1 proteins share an N-terminal FERM domain, 
a spectrin-actin binding (SAB) domain, and a characteristic C-terminal domain 
(CTD). The sequence flanking these domains are sequentially termed U1, U2, and 
U3 regions, which are less conserved and may be unique to each member of this 
protein family. 
The N-terminal FERM domain is believed to be responsible for binding to the 
membrane proteins. A study on the crystal structure of 4.1R FERM domain revealed 
three subdomains, the N-, α-, and C-lobes, that assemble into a clover leaf-like 
structure. Furthermore, each lobe contains distinct site(s) for membrane protein 
binding and this would count for the ability of FERM binding to a whole spectrum 
of membrane proteins. Right adjacent to the FERM domain appears a region which 
is not well defined previously. Although it is very conserved among protein 4.1 
members, there is no predictable binding ability attributed to this region. The 
identification of two serine residues, which could be phosphorylated by PKA and 
PKC, leads to the hypothesis that this region might regulate the binding of 4.1 
proteins to other proteins. The primary amino acid sequence of the SAB domain is 
highly conserved in mammalian 4.1 proteins, implying a functional conservation. 
Although it is reported that the SAB domain of 4.1N is impotent in spectrin-actin 
binding, 4.1R, 4.1B and 4.1G are capable of binding to spectrin-actin through their 
respective SAB domain. As compared with FERM and SAB domains, less 
knowledge is available on the C-terminal domain (Diakowski et al, 2006). In MDCK 
cells, 4.1R binds tight junction proteins, ZO-1 and ZO-2, through the C-terminal 
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domain (Mattagajasingh et al, 2000). 
 
3.1.2.2. Alternative splicing of 4.1 pre-mRNAs 
Besides sequence and structural similarities, it should also be noted that all 
protein 4.1 family members experience extensive pre-mRNA alternative splicing 
events. Alternative splicing, by which exons of the transcript of a gene are 
reconstructed, occurs very common and contributes to protein diversity in eukaryotes 
remarkably. It is conservatively estimated that more than 10,000 human genes with 
multiple exons are alternatively spliced (Johnson et al, 2003). Pre-mRNA splicing is 
done through complex machinery, spliceosome, comprising of small nuclear 
ribonucleoproteins, which cleave the boundaries between exons and introns 
following some consensus sequences and allow assemble of exons (Jurica and 
Moore, 2003). Alternative splicing is regulated by trans-acting proteins, including 
enhancers and repressors. Together, these proteins control how the exons are 
reconnected under different cellular conditions (Caceres and Kornblihtt, 2002).  
The complex pre-mRNA processing might meet the tissue-specific 
requirements of differential expression of 4.1 protein isoforms. The splicing events 
frequently occur at exons encoding the amino acid sequence corresponding to the 
SAB domain and the flanking regions in all 4.1 proteins (Tan et al, 2005; Parra et al, 
2008; Wang et al, 2010). Coincidently, the Drosophila orthologue of protein 4.1, 
coracle, lacks the SAB domain (Baumgartner et al, 1996). This coincidence 
somehow may be due to an evolutionary requirement of spectrin-acting binding. 
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3.1.3. The PTPH proteins and others 
PTPH proteins are FERM domain-containing protein tyrosine phosphatases. 
PTPH1, isolated from Hela cells, and PTPMEG, isolated from human MEG-1 cells, 
are the only two well-defined members belonging to this protein family so far (Gu et 
al, 1991; Yang and Tonks, 1991). These proteins are characterized by an FERM 
domain in the N-terminus and a protein tyrosine phosphatase (PTP) catalytic domain 
in the C-terminus. The fragment in between FERM domain and PTP catalytic 
domain varies in PTPH1 and PTPMEG. The roles of this intermediate region are not 
fully elucidated but generally predicted to bind protein partners and regulate the 
enzymatic activity of the C-terminal catalytic domain (Zhang et al, 1995; Gu and 
Majerus, 1996). 
Talin, consisting of two gene products TLN1 and TLN2, is another frequently 
studied FERM protein in protein 4.1 superfamily (Collier and Wang, 1982; 
O'Halloran et al, 1985). Like all other FERM proteins, the N-terminal region of talin 
bears the FERM domain, which could be divided into 3 subdomains. The difference 
in FERM domain structure of talin and other FERM proteins is that two of the 
FERM subdomains of talin also contribute to F-actin binding ability. Followed the 
FERM domain is a long rod fragment, which comprises of up to 60 alanine-rich 
repeats and contains a significant portion of α-helices. There are several intermittent 
sites in the rod fragment with vinculin-binding activity. The long rod fragment ends 
with a well-defined C-terminal actin-binding site (ABS) (Nuckolls et al, 1990; 
Kaufmann et al, 1991). 
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Despite the numerous numbers of proteins being classified as members of 
protein 4.1 superfamily, the story of identifying and characterizing new proteins in 
this family has not ended. As time goes, more proteins will be added to this pool.  
 
3.2. Biological functions of protein 4.1 superfamily. 
The exploration of functional roles of protein 4.1 superfamily members can be 
traced back to 1970s when 4.1R was first discovered. Although it is still far from 
completing our knowledge on their functional significance, many fundamental 
functions, including organizing structures of cells and tissues, transducing signals, as 
well as intracellular trafficking, have been unveiled over the past few decades. In 
view of similarities among these functions, it seems almost all of these functions can 
be, if not completely, partially attributed to the ability of proteins in this family to 
bind membrane proteins and/or actin cytoskeleton. Proteins of this family often 
exhibit functional redundancy, particularly in vertebrate, although functional 
diversity of different members is also not uncommon (See below for the functional 
review of a selected group of FERM proteins). 
 
3.2.1. Functions of ERM proteins 
The ERMs not only serve as a pivotal linker between the plasma membrane 
proteins and the cortical actin cytoskeleton to control the cell shape, cell adhesion, 
and cell motility, but also actively participate in several signalling pathways to 
regulate cellular activities.  
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Firstly, activated ERM proteins are able to bind membrane proteins and connect 
them to F-actin. Virtually like all FERM proteins, the FERM domain in the 
N-terminus of ERMs is capable of binding membrane proteins. The association 
could be directly accomplished between ERMs and their membrane partners or 
indirectly mediated by some scaffolding proteins, including ERM-binding 
phosphoprotein 50 (EBP50) and sodium-hydrogen exchanger type 3 kinase A 
regulator protein (E3KARP) (Bretscher et al, 2000). For instance, the first identified 
ERMs membrane binding partner, a hyaluronate receptor CD44, can interact with 
ERMs directly via the juxtamembrane regions (Tsukita et al, 1994). Other direct 
ERMs-interacting membrane proteins would include CD43, intercellular adhesion 
molecular 1 (ICAM-1), ICAM-2, sodium-hydrogen exchanger 1 (NHE-1), 
syndecan-2 and β-dystrophin (Yonemura et al, 1998; Denker et al, 2000; Granes et al, 
2000; Granes et al, 2003; Spence et al, 2004). In addition to direct association with 
membrane proteins, FERM domain of ERMs has a strong binding ability to the 
PDZ-domain of adaptor protein EBP50 and E3KARP (Reczek et al, 1997; Nguyen et 
al, 2001). The ability of EBP50 and E3KARP interacting with a plethora of 
membrane proteins, such as NHE3, cystic fibrosis transmembrane conductance 
regulator (CFTR), β2 adrenergic receptor, platelet-derived growth factor receptor 
(PDGFR), and epidermal growth factor receptor (EGFR), might help establish 
indirect association between these proteins and ERMs (Short et al, 1998; Yun et al, 
1998; Cao et al, 1999; Kurashima et al, 1999). Indeed, it is found that EBP50 
connects ezrin to NHE3 in the epithelial cells of kidney proximal tubule (Weinman 
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et al, 2000). On the other hand, the unmasked ERMs can bind F-actin with their 
exposed actin-binding site in the C-terminus, thus establish a linkage between the 
actin cytoskeleton and membrane proteins (Gautreau et al, 2002). This connection is 
of important physiological significance. First of all, it apparently contributes to the 
organization of plasma membrane in a dynamic fashion. As mentioned previously, 
the F-actin binding ability of ERMs can be regulated by phosphorylation by various 
types of kinases. The regulation in the strength of the linkage between membrane 
proteins and actin-cytoskeleton could, in turn, not only alter the biophysical 
properties of plasma membrane, but also modify the membrane content of receptors 
(Fievet et al, 2007). Moreover, the linkage between actin-cytoskeleton could also 
regulate the membrane retraction and filapodia protrusion, which are important in 
control cell migrations (Paglini et al, 1998; Gatto et al, 2007).   
Furthermore, ERMs also actively participate in several signal-transduction 
pathways. One ERMs-involving signalling pathway, that receives most 
investigations, is the RhoA-mediated signals transduction. Conventionally, ERMs 
are thought to be the effectors working downstream of the Rho-signalling (Bretscher, 
1989; Nakamura et al, 1995). In an early study on the Rho-induced cytoskeleton 
remodeling, the translocation of cytoplasmic ERMs to the plasma membrane 
following the Rho activation by GTPγs appeared to be essential (Hirao et al, 1996). 
Recent investigations have revealed that ERMs regulate RhoA activity upstream as 
well. The findings that ERMs could interact with Rho GTPase regulators including 
RhoGAP, RhoGEF and RhoGDI suggest a control of Rho activity by ERMs 
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(D'Angelo et al, 2007; Prag et al, 2007). Besides, the participation of ERMs in 
hedgehog signalling and some other membrane receptors signalling have attracted 
more and more interests nowadays (Molnar and de Celis, 2006;McClatchey and 
Fehon, 2009).  
 
3.2.2. Functions of protein 4.1 molecules 
Protein 4.1 molecules are widely expressed in different tissues and organs. 
Investigations have unveiled a broad range of functional roles of 4.1 proteins from 
maintaining the cell shape (e.g. 4.1R in red blood cell), organizing specialized tissue 
architecture (e.g. 4.1B in neuronal paranodes), to controlling the metastasis of cancer 
cells (e.g. 4.1B and 4.1R as cancer suppressors). Despite the high sequence 
homogeneity among 4.1 proteins, there exist very diverse tissue- and/or cell-specific 
enrichment and functions. 
 
3.2.2.1. 4.1R 
4.1R is the erythroid protein 4.1 paralogue first identified in red blood cells, 
although later studies have shown that different isoforms of 4.1R widely spread 
among tissues (Yu and Steck, 1975; Luna et al, 1979; Cohen et al, 1982). Early 
functional investigations mainly focused on 4.1R as a linker to establish association 
between membrane proteins and actin cytoskeleton and maintain the shape of red 
blood cells (Fowler and Taylor, 1980; Cohen and Korsgren, 1980; Cohen and Foley, 
1982; Sato and Ohnishi, 1983; Anderson and Lovrien, 1984). However, it becomes 
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more apparent now that 4.1R is not only a scaffold, but also exerting other important 
functions in erythrocytes and other nucleated cells as well. 
First of all, 4.1R is of premier importance in red blood cells. The best 
characterized function is that 4.1R connects plasma membrane proteins to the 
cytoskeleton. It was found that 4.1R forms a ternary protein complex with an 
integral membrane protein, glycophorin C (GPC), and a MAGUK protein, p55 
(Anderson and Lovrien, 1984; Alloisio et al, 1993; Marfatia et al, 1994; Marfatia et 
al, 1995). The binding interface is constituted by the 4.1R FERM domain (Hemming 
et al, 1995). The association of 4.1R with GPC and p55 is likely to be modulated by 
calmodulin, as it has been demonstrated that binding to calmodulin markedly 
decreased the association between 4.1R and GPC, as well as between 4.1R and p55 
(Nunomura et al, 2000; Han et al, 2000). On the other hand, 4.1R form a complex 
with spectrin and actin via the SAB domain as well. Through the linkage established 
by 4.1R between the membrane proteins and cytoskeleton, the cells gain profound 
membrane mechanical stability (Fowler and Taylor, 1980; Cohen and Foley, 1982; 
Husain et al, 1983). The identification of 4.1R Serine-312 as a phosphorylation site 
by PKC and subsequent demonstration that phosphorylation decreased its ability to 
form 4.1R/GPC/p55 and 4.1R/spectrin/actin complex suggest that 4.1R could 
regulate erythroid membrane properties through phosphorylation as well besides 
calmodulin-binding (Ling et al, 1988; Danilov et al, 1990; Manno et al, 2005). 
Besides stabilizing erythroid membrane, 4.1R has also been implicated in the late 
stage of erythroid differentiation (also referred as terminal differentiation). There are 
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two major isoforms of 4.1R, the 135 kD isoform and the 80 kD isoform, expressed in 
erythrocytes. The 135 kD-4.1R is mainly expressed in early erythroblasts and 
completely absent from the mature erythrocytes, whereas the 80 kD-4.1R only come 
into being at the later stage of differentiation (Gascard et al, 1998; Deguillien et al, 
2001). The two isoforms are resulted from alternatively pre-mRNA splicing and 
different by an N-terminal “head piece” consisting of 209 amino acids (Parra et al, 
2003). The two isoforms exhibit quite different binding affinity to both GPC and p55. 
Furthermore, the interactions are differentially regulated by calmodulin binding. 
While the 135 kD-4.1R is regulated by calmodulin in a Ca2+-dependent manner, the 
80 kD-4.1R is modulated in a Ca2+-independent way (Nunomura et al, 2009). The 
finding that a differentiation-inducible Fox-2 could regulate 4.1R pre-mRNA 
splicing further supports 4.1R is crucial in erythrocyte differentiation (Ponthier et al, 
2006). The significance of 4.1R in red blood cells is also demonstrated by hereditary 
haemolytic anaemias caused by mutations in erythroid skeletal proteins including 
4.1R (Shi et al, 1999; Birkenmeier and Barker, 2004). An intriguing phenomenon is 
that the parasite, Plasmodium falciparum, also targets 4.1R in malaria-infected red 
blood cells (Waller et al, 2003). This probably also illustrates the importance of 4.1R 
in erythrocytes. 
Secondly, 4.1R plays an important role in modulating mitosis. This notion 
probably arose from the observation that the 135 kD-4.1R partially colocalized with 
nuclear mitotic apparatus (NuMA) to the interphase nucleus in MDCK cells and 
translocated to the spindle poles in mitosis (Mattagajasingh et al, 1999). Further 
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research works confirmed that 4.1R is crucial for assembling and stabilizing the 
mitotic spindle as well as the centrosome-nucleated microtubules (Huang et al, 2004; 
Perez-Ferreiro et al, 2004). This function has been attributed to the C-terminal 
domain of 4.1R for its ability to associate with tubulin both in vitro and in vivo 
(Perez-Ferreiro et al, 2001a; Perez-Ferreiro et al, 2001b). More recently, the 
importance of 4.1R in mitosis was further addressed by a major failure in cell cycle 
including disruption of centrosome, alteration in cell cycle progression, and 
perturbation of mitotic spindles following a downregulation of 4.1R (Krauss et al, 
2008). It is suggested that the mitosis-related functions such as binding NuMA and 
tubulin are regulated by phosphorylation of a special threonine and serine residue by 
p34cdc2 kinase (Huang et al, 2005; Trevino et al, 2010). 
Furthermore, 4.1R is also implied in the formation of cell junctions. In 
confluent MDCK cells, 4.1R was found to localize to the tight junctions and interact 
with peripheral tight junction proteins, ZO-1 and ZO-2, through its C-terminal 
domain (Mattagajasingh et al, 2000). This interaction is believed to be important in 
stabilizing the tight junction structure by connecting the junctional complex to the 
actin cytoskeleton via spectrin-actin binding. The finding that 4.1R binds to and 
distributes human disc large (hDlg) protein, which is involved in epithelial 
polarization, to the cell-cell contact sites in confluent MDCK boosts the evidence of 
4.1R’s involvement in junction formation (Hanada et al, 2003). Besides, 4.1R also 
directly associates with β-catenin and connect the E-cadherin/β-catenin complex to 
the actin cytoskeleton to maintain the integrity of adherens junctions (Yang et al, 
 43
INTRODUCTION 
2009). Together, these discoveries indicate an essential structural role of 4.1R in 
junctional assembly.  
In addition, it is not rare to find involvements of 4.1R in CNS-related structures 
and functions. 4.1R was found to be restricted in neuronal populations, particularly 
the granular neurons in the dentate gyrus and cerebellum. Mice lacking 4.1R 
displayed neurobehavioral defects in learning, movement, balance and coordination 
(Walensky et al, 1998). In a study of 4.1 proteins, it was found that the 80 kD-4.1R 
was highly enriched in the postsynaptic density preparation and coprecipitated with 
neurofilament L and α-internexin, suggesting a potential role in maintaining the 
postsynaptic density protein network and architecture (Scott et al, 2001). In addition, 
4.1R also interacts with metabotropic glutamate receptor type 8 (mGluR8), 
indicating 4.1R could also organize the neurotransmitter receptors anchoring in the 
postsynaptic density (Rose et al, 2008).  
Besides the aforementioned functions, 4.1R is frequently implicated in various 
other cellular structures and events. Through the study in 4.1R knockout mice model, 
it was found that 4.1R might possess a novel function in modulating the properties of 
several cardiac ion channels and consequently influencing the cardiac 
electrophysiology (Cunha and Mohler, 2008; Baines et al, 2009). In T cell, 4.1R 
seems negatively regulating T cell activation by binding to linker-for-activation of T 
cell (LAT) protein and inhibiting its phosphorylation by ZAP70 (Cannon, 2009; 
Kang et al, 2009b). Other functional implications of 4.1R include regulating skeletal 
muscle myofibers contraction and controlling Xenopus oogenesis 
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(Kontrogianni-Konstantopoulos et al, 2000; Carotenuto et al, 2009). 
3.2.2.2. 4.1B 
4.1B, also called brain 4.1 protein, was the most prominently expressed 4.1 
protein in rat brain (Parra et al, 2000). To date, functional studies of 4.1B have 
revealed two major functions of 4.1B as a tumor suppressor controlling cancer 
progression and metastasis and as a neuronal paranodal scaffolding protein 
maintaining the paranodal structure during myelination, although some other 
functions have also been implied.  
Firstly, 4.1B negatively regulates tumorigenesis. The alterations in 4.1B gene 
expression were commonly found in several cancer diseases, including meningiomas, 
non-small cell lung cancer, etc, suggesting a pivotal role of 4.1B in controlling 
cancer progression (Terada et al, 2003; Nunes et al, 2005; Kikuchi et al, 2005; 
Dickinson et al, 2009). It is believed that 4.1B could suppress cancer cell growth on 
the one hand, and prevent the migration and invasion of the carcinoma, i.e. control 
the metastasis on the other. First of all, 4.1B controls tumor cell growth. In 
meningioma, 4.1B is recruited to the plasma membrane through the U2 region, and 
activates the c-Jun-NH(2)-kinase (JNK) pathway, which will subsequently result in 
meningioma growth suppression (Robb et al, 2005; Gerber et al, 2006). Another 
possible mechanism through which 4.1B suppresses cell growth is that 4.1B might 
bind protein arginine N-methytransferase 3 (PRMT3) and modulate the 
post-translational methylation (Singh et al, 2004; Jiang et al, 2005b). Furthermore, 
4.1B also regulates cancer cell migration. In a study to explore possible role of 4.1B 
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in the mechanism of metastasis, cells treated with 4.1B RNAi showed an abnormal 
morphology with significant less stress fibers and migrate at twice the speed of 
normal cells (Cavanna et al, 2007). Thus, loss of 4.1B in metastatic cells might 
induce a loss of actin stress fiber and concomitant increased cell motility. The 
finding that 4.1B interacts with αβ8-integrin might also suggest 4.1B could somehow 
mediate cell-matrix adhesion and reduce the cell migration (McCarty et al, 2005).  
Secondly, 4.1B has an essential role in organizing paranodal and juxtaparanodal 
architecture in myelinated axons. Early immunohistochemical studies revealed that 
4.1B highly specifically localized to the neuronal paranodal membrane region of 
myelinated axons (Ohara et al, 2000). It provoked the hypothesis that 4.1B might 
play a part in myelination. Subsequent investigation found that 4.1B could associate 
with an axoglial junctional protein caspr (also called paranodin) and was of essence 
to its retention in the axolemma (Poliak et al, 2001). Besides, researchers also found 
that 4.1B could directly bind Caspr2 and render it surface localization at the 
juxtaparanodal axolemma (Denisenko-Nehrbass et al, 2003). A recent study on the 
organizing of paranodal and juxtaparanodal protein complex suggested that, while 
the Caspr/4.1B association at the paranodal junction generated a membrane barrier to 
prevent diffusion of Kv1 from juxtaparanodal to the nodal regions, the Caspr2/4.1B 
interaction in juxtaparanodes kept Kv1 at site (Horresh et al, 2010). In addition, the 
finding of 4.1B localization at the axonal membrane of a subgroup of unmyelinated 
enteric nerve fibers, which were surrounded by Schwann cells, suggests that 4.1B 
probably also guide the axon-glial interaction at early myelination stage apart from 
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maintaining the paranodal and juxtaparanodal architecture (Terada et al, 2004).  
Finally, 4.1B probably also participates in controlling epithelial cell polarization 
and membrane localization of several surface receptor proteins. For instance, a 200 
kD 4.1B isoform was found to associate with Golgi apparatus in MDCK and HBE 
cells and seemingly be responsible for the maintaining of Golgi structure and 
membrane trafficking of a whole bunch of polarizing complex proteins such as 
Na+/K+ ATPase, ZO-1, and ZO-2 (Kang et al, 2009b). Moreover, 4.1B, together with 
synaptic adhesion molecule 1 (SynCAM1), increased the frequency of NMDA 
receptor-mediated mEPSCs and area of postsynaptic contact in HEK293/neuron 
coculture, indicating that 4.1B facilitates SynCAM1 mediated recruitment of NMDA 
receptors (Hoy et al, 2009).  
 
3.2.2.3. 4.1N 
4.1N is a neuron-enriched protein 4.1 paralogue. Immunohistochemical staining 
revealed a distinct punctate-like pattern, later confirmed to be a synaptic localization, 
in granule neurons in dentate gyrus and cerebellum. Colocalization with PSD-95 and 
GluR1 suggest it is a postsynaptic protein (Walensky et al, 1999).  
The major function of 4.1N well-established hitherto is anchoring various types 
of neurotransmitter receptors to the postsynaptic membrane. Firstly, it regulates the 
membrane insertion of AMPA receptors. Protein 4.1N binds the membrane proximal 
region of GluR1 via the C-terminal domain. Disruption of this association or 
perturbation in actin cytoskeleton markedly reduces the surface expression of GluR1, 
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suggesting 4.1N serves to stabilize the postsynaptic membrane localization of GluR1 
by anchoring it to the actin cytoskeleton (Shen et al, 2000). The interaction between 
GluR1 and 4.1N is seemingly regulated by phosphorylation of GluR1 by PKC and 
palmitoylation of GluR1 (Hayashi et al, 2005; Lin et al, 2009). Secondly, 4.1N may 
also affect the surface localization of D2 and D3 dopamine receptors. 4.1N was 
found to bind dopamine receptor through the C-terminal domain and overexpression 
of CTD-truncated 4.1N significantly reduced the surface expression of 4.1N (Binda 
et al, 2002). Consistent with this finding, 4.1N and D2 dopamine receptor expression 
increased concomitantly after antipsychotics treatment (Kabbani and Levenson, 
2006).  
4.1N might also involve in cell polarization. Association between 4.1N and 1, 4, 
5-trisphosphate receptor (IP3R) is detected in epithelial cells and neurons, both of 
which are well known polarized cells (Maximov et al, 2003; Fukatsu et al, 2004; 
Fukatsu et al, 2006). Furthermore, 4.1N is necessary and sufficient to translocate 
IP3R to the basolateral membrane of confluent MDCK cells, implying a role of 4.1N 
in epithelial membrane polarization (Zhang et al, 2003).  
 
3.2.2.4. 4.1G 
4.1G was identified as a protein 4.1 paralogue in 1998 by Parra et al with a very 
general expression profile among tissues (Parra et al, 1998). In the nervous system, 
4.1G protein expression was detected mainly in microglia in the CNS and in 
Schwann cells in the PNS in vivo (Ohno et al, 2005; Ohno et al, 2006). However, the 
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expression of 4.1G in other nerve cells has also been implicated. In the in vitro 
cultured hippocampal neurons, 4.1G was demonstrated to colocalize with metabolic 
glutamate receptor subtype 1 alpha (mGLU 1α), whereas in a genomic study of 
oligodendrocyte differentiation, 4.1G mRNA was found in the oligodendrocyte 
lineage and highly upregulated during OPC to OL transition (Lu et al 2004a; Dugas 
et al, 2006).  
Unlike 4.1R, the functional investigation on 4.1G is patchy and the roles of 
4.1G are still elusive so far. Nevertheless, some immunohistological studies and in 
vitro binding assays provide us valuable clues for further deciphering 4.1G functions. 
For example, in mouse seminiferous tubules, 4.1G was found to localize at the 
membranes of Sertoli cells, spermatogonia, as well as early spermatocytes. The 
staining displayed a line pattern, especially at the contact regions of Sertoli cells and 
germ cells (Terada et al, 2005). Further study revealed that 4.1G was colocalized 
with cell adhesion molecule 1 (CADM-1) in serminiferous tubules and also 
coimmunoprecipitated with CADM-1 in testicular tissue lysate (Terada et al, 2010). 
Together, these results suggest that 4.1G might participate in cell adhesion and 
formation of cell junctions. Besides, 4.1G could probably also function to anchor 
and organize membrane receptors. In COS-7 cells transiently coexpressing 4.1G and 
parathyroid hormone-related protein receptor (PTHR), 4.1G could facilitate the 
surface localization of PTHR in the plasma membrane through the C-terminal 
domain (Saito et al, 2005). Other evidences supporting this contention come from 
the ability of 4.1G binding other receptor such as, FcγR1, A1AR, mGluR1α, and 
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mGluR8 (Lu et al, 2004a; Lu et al, 2004b; Beekman et al, 2008; Rose et al, 2008). In 
addition, 4.1G might be also involved in tumorigenesis and/or cancer metastasis, as 
in a clinical study of patient who died from ependymal tumor, alteration of 4.1G 
gene had high correlation with early death or residual and recurrent tumor (Zheng et 
al, 2009).  
In view of 4.1G function, there is a high degree of function redundancy between 
4.1G and other 4.1 proteins. For example, the heart of 4.1R-knckout mice shows an 
increased expression of 4.1G, somehow suggesting that 4.1G might partially 
compensate the loss of 4.1R functions (Stagg et al, 2008). In addition, although 4.1G 
is suggested to bind and help synaptic trafficking of GluR1, the 4.1G-knockout mice 
do not show substantial change in glutamergic synaptic signal-transmission and 
long-term potentiation (Wozny et al, 2009). The functional redundancy among 4.1 
proteins and the complex compensation events definitely benefit the physiological 
normality, but, from researchers’ point of view, hinder the unveiling of 4.1G 
functions.   
 
4．Objectives of the present study 
As described in the previous section, the expression patterns of 4.1G in the 
CNS are seemingly inconsistent as shown/implicated by the several studies, and 
remain largely unclear. Since there are complex RNA processing events for 4.1 
family proteins (section 3.1.2), it is highly possible that different 4.1G isoforms are 
expressed in the CNS and differentially localize to the CNS cell types. Functionally, 
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4.1 proteins have been frequently implicated in the intercellular interactions directly 
and/or indirectly in a wide spectrum of cells and tissues (section 3.2.2). Based on the 
homologies in both primary amino acid sequence and domain structures among 4.1 
family members, it is presumed that 4.1G would have functional roles similar to 
other 4.1 protein members in intercellular signaling and communication. Besides, it 
is implicated that 4.1G could involve in controlling/regulating oligodendrocyte 
differentiation as a high upregulation of 4.1G mRNA during OPC to OL transition 
has been observed. Since protein 4.1 molecules linked membrane proteins to 
intracellular cytoskeleton, it might control the morphological differentiation during 
oligodendrocyte lineage progression.  
Therefore, the current study mainly focused on the ensuing objectives: 
1. Characterizing molecular features of 4.1G expressed in CNS; 
2. Studying the cellular expression profile of 4.1G in CNS; and 
3. Exploring functional roles of 4.1G in oligodendrocyte differentiation 
and in the formation of tight junctions among cultured cells.  
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1. Chemicals 
All the molecular biology-grade or HPLC-grade chemicals used in the study 
were obtained commercially for research and diagnostic purposes. The complete list 
of chemicals is available in Table 2-1. 
Table 2-1. List of chemicals used in the present study. 
Chemicals Manufactures 
30% acrylamide and bis-acrylamide solution, 37.5:1 Bio-rad (Hercules, CA) 
Ammonium persulfate (APS) Bio-rad 
Bromo-chloro-indolyl-galactopyranoside (X-gal) Bio-rad 
N,N,N',N'-Tetramethylethylenediamine (TEMED) Bio-rad 
Sodium dodecyl sulfate (SDS)  Bio-rad 
Triton-X-100 Bio-rad 
Tween-20 Bio-rad 
Agarose  Invitrogen (Carlsbad, CA) 
Dithiothreitol (DTT) Invitrogen 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) Invitrogen 
1,2-Isopropanol Merck (Darmstadt, Germany)
Ethylenediaminetetraacetic acid (EDTA) Merck 
Ethyleneglycoltetraacetic acid (EGTA) Merck 
Ethanal Merck 
Glycerol Merck 
Magnesium chloride, hexhydrate (MgCl2) Merck 
Methanal  Merck 
Potassium chloride (KCl) Merck 
Sodium chloride (NaCl) Merck 
Sodium dihydrogen phosphate, monohydrate (NaH2PO4) Merck 
Tris base Merck 
4′,6-Diamidino-2-phenyindole, dilactate (DAPI) Sigma-aldrich (St Lious, MO)
Agar Sigma-aldrich 
Ampicillium sodium Sigma-aldrich 
Bromophenol blue Sigma-aldrich 
Kanamycin sulfate Sigma-aldrich 
Ponceau S Sigma-aldrich 
Select yeast extract Sigma-aldrich 
Trypton Sigma-aldrich 
Paraformaldehyde (PFA) TAAB (England, UK) 
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2. Experimental animals 
All animal experiments were approved by the Institutional Animal Care and 
Use Committee at the National University of Singapore, and carried out in strict 
accordance with Regulations and Guidelines on the Care and Use of Animals for 
Scientific Purposes by the National Advisory Committee for Laboratory Animal 
Research (NACLAR, Singapore). Persistent efforts are made to minimize the 
number of animals used and their suffering.  
For antibody generation, three New Zealand White rabbits were injected with 
antigens once every 2 weeks (described below). Ten days after the sixth injection, 
blood was withdrawn from the rabbits under anesthesia (ketamine, 35 mg, and 
xylazine, 5 mg/kg of body weight). The animals were then sacrificed by intracardiac 
injection of Nembutal (100 mg/kg of body weight). 
 For Western blots and immunoprecipitation, two adult male Wistar rats were 
anesthetized and euthanized with Nembutal (100 mg/kg of body weight, i.p.), and 
their brain and various other tissues and organs were dissected and used for 
extracting the total protein by using Tissue Protein Extract Reagent (Pierce, 
Rockford, IL). 
 For in situ hybridization, immunoperoxidase, and immunofluorescence 
labelling, adult male Wistar rats were transcardially perfused (Rinsing solution: 0.5% 
PFA and 0.9% NaCl in 0.1 M PB; fixative solution: 3% PFA in 0.1M PB) under 
anesthesia. Their CNS were then carefully dissected out, post-fixed for 3 hours in the 
fixative solution, dehydrated in 30% sucrose for an overnight period, and sectioned 
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using a cryostat. For immunoperoxidase-based electron microscopic study, adult 
male Wistar rats were transcardially perfused (rinsing solution: 0.5% PFA and 0.9% 
NaCl in 0.1M phosphate buffer [PB]; fixative solution: 3% PFA, 0.1% 
Glutaraldehyde and 0.9% NaCl in 0.1M PB) under anesthesia. Their brain and spinal 
cord were dissected out and sectioned with a vibrotome. 
 
3. Cloning, mammalian expression plasmids, and Dicer substrate small 
interfering RNA  
4.1G cDNA fragments were amplified from a commercial rat hippocampal 
cDNA library or cDNA reverse-transcribed from total rat brain RNA, and sequenced 
with a BigDye terminator v3.1 cycle sequencing kit. The Open Reading Frame (ORF) 
of rat 4.1G was cloned from the aforementioned cDNA fragments by Polymerase 
Chain Reaction (PCR).  
To elucidate the functional roles of 4.1G, the nucleotide sequences encoding 
4.1G (927 amino acid residues) and 4.1G residue 492-927, 1-807, and 492-807, were 
amplified by PCR and either subcloned into a Hemaggutinin (HA)-tagged pXJ40 
vector (Manser et al, 1997) or a pEGFP-c1 vector (Clontech, Palo Alto, CA), 
generating HA- or GFP-tagged 4.1G, 4.1GΔN, 4.1GΔC and 4.1GΔNC. Two Dicer 
substrate small interfering RNA (DsiRNA) duplexes against rat 4.1G 
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Table 2-2. Oligos used in the present study. 
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4. In vitro expression and antibody generation 
Nucleotide sequences encoding 4.1G amino acid residues 11-87 and 630-705 
were subcloned in to a pET41a vector (Novagen, Madison, WI) for in vitro 
expression of GST-4.1G U1 and GST-4.1G U3 fusion proteins in a bacterial host, 
E.coli BL21DE3 strain with IPTG induction. The GST-4.1G U1 and GST-4.1G U3 
fusion proteins were glutathione S-transferase (GST)-affinity purified by using GST 
bulk purification module (GE healthcare, UK) according to the manufacturer’s 
procedures.  
The purified GST-4.1G U1 and GST-4.1G U3 fusion proteins were used to 
immunized the New Zealand White rabbits (For each fusion protein, n = 3; Two of 
the rabbits each were injected with one of the fusion proteins, and another rabbit 
with both.) for the generation of anti-4.1G polyclonal antibodies. Briefly, 
approximate 1 mg of each fusion protein was resolved by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and visualized by 
Commassie blue staining. The corresponding gel bands were excised, extensively 
destained, and grinded into tiny beads. The gel beads with GST-4.1G U1 or U3 
fusion protein were mixed with about an equal volume of complete Freund’s 
adjuvant (for priming injection; Sigma-Aldrich) or incomplete Freund’s adjuvant 
(for boost injection; Sigma-Aldrich). The mixture was emulsified and 
subcutaneously injected into the rabbits in several discrete sites at the back every two 
weeks. Ten days after the final boost injection (i.e. the sixth injection), the blood was 
collected and the anti-sera were separated.  
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Purification of the anti-4.1G U1 and anti-4.1G U3 antibodies was performed as 
described by Li and coworkers (Li et al., 2007), with minor modifications. The 
GST-4.1G U1 and GST-4.1G U3 recombinant proteins were resolved on SDS-PAGE 
and electroblotted onto polyvinylidene difluoride (PVDF) membranes (PerkinElmer, 
Boston, MA). The recombinant proteins were visualized by Ponceau S staining and 
the membrane slices with the recombinant proteins were minced and incubated with 
respective anti-sera (1:1 diluted in cold PBS to reduce the viscosity) at 4°C with 
gentle agitation overnight. Membranes were then washed in cold PBS three times. 
Antibodies specifically bound to the antigenic peptides immobilized on the 
membranes were eluted by incubating the membranes in 0.1 M Glycine-HCl buffer 
(pH 2.5) with vigorous shaking for 5 minutes. The eluted antibody solution was 
neutralized by adding in 1 M Tris buffer (pH 8.0). The resulted antibodies were 
incubated with minced PVDF membrane with GST to remove potential anti-GST 
polyclonal antibody. 
 
5. Cell culture 
OLN-93 cells, spontaneously transformed cells in primary rat brain glial culture 
and with antigenic properties resembling postnatal 5- to 10-day old cultured rat brain 
oligodendrocytes, were routinely cultured in DMEM (Sigma-Aldrich) supplemented 
with 10% fetal bovine serum (FBS) and passaged twice a week. To demonstrate the 
localization of 4.1G at the tight junctions, 4 × 105 OLN-93 cells were either seeded 
in a 24-well plate or 4-well chamber slide (BD biosciences, Bedford, MA). After 
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culturing for 5 days with daily medium renewal, cells in 24-well plate were fixed 
with 3% paraformaldehyde (PFA) for immunofluorescence labelling, and cells in 
4-well chamber slide were fix with 4% PFA supplemented with 0.1% 
glutaraldehydrate for immunoelectron microscopic study. All the plastic-wares used 
in cell cultures were purchased from NUNC or Falcon. 
 
6. Transfection 
For overexpression or DsiRNA silencing of 4.1G, OLN-93 cells were 
transfected using MP-100 Microporator (Digital Bio Technology, South Korea) for 
plasmid DNA or Lipofactamine RNAiMAX (Invitrogen) for DsiRNAs according to 
the manufacturers’ instructions.  
Forty-eight hours after transfection, cells were harvested and lysed for Western 
blotting by M-PER Mammalian Protein Extraction Regent (Pierce, Rockford, IL), or 
fixed with 3% PFA for immunofluorescence labelling. To study effects of 4.1G on 
tight junctions, cells were maintained with daily medium renewal for another 5 days 
after reaching 100% confluency before fixed with 3% PFA.  
 
7. Calcium switch experiment 
For calcium switch experiment, OLN-93 cells were maintained for 5 days after 
reaching 100% confluency to allow the assembly of tight junctions. To deplete Ca2+, 
the cells were rinsed with Ca2+-free PBS twice and incubated in Ca2+-free solution 
(145 mM NaCl, 5 mM KCl, 1.3 mM MgCl2, 1.2 mM NaH2PO4, 10 mM Glucose, 20 
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mM HEPES, and 1 mM EGTA; pH 7.4) for 4 hours for the complete disruption of 
tight junctions. Then the cells were incubated in DMEM supplemented with 10% 
FBS for 4 hours before fixed with 3% PFA. 
 
8. Western blotting 
Protein samples were quantified by using BCA protein assay kit (Pierce). 
Approximate 20 μg of protein sample per well was resolved by SDS-PAGE and 
electro-transferred onto PVDF membranes. After being blocked by 
PBS-T-NGS-milk (0.05 Tween-20, 2% normal goat serum, and 5% non-fat milk 
[Bio-Rad] in PBS), membranes were probed with primary antibodies diluted in 
PBS-T-NGS-milk at RT for an overnight period. After washes with 0.05% Tween-20 
in PBS, the membranes were incubated with alkaline phosphatase-conjugated goat 
anti-mouse or -rabbit IgG secondary antibodies at RT for 1 hour. Immunodetection 
was performed using CDP-Star chemiluminescence reagent (Roche, Basel, 
Switzerland) and Kodak BioMax light films (Sigma). 
 
9. Immunoprecipitation and mass spectrometry  
Immunoprecipitation was performed using Protein G Immunoprecipitation Kit 
(Sigma-Aldrich) as the manufacturer instructed. Briefly, 2 mg of adult rat brain 
lysate, obtained using T-PER Tissue Protein Extraction Reagent (Pierce) 
supplemented with Protease Inhibitor Cocktail (Pierce), was first precleared with 30 
μl of Protein G-Sepharose 4B recombinant at 4 °C for 3 h. The precleared 
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supernatant was incubated with 5 μg of anti-4.1G U3 or normal rabbit IgG and 30 μl 
of Protein G-Sepharose 4B recombinant at 4 °C for 3 h. The immunopreicipates 
were collected with the spin column provided, resolved on SDS-PAGE, and 
visualized using a silver staining kit (Bio-Rad). The proteins immunopricipitated 
with anti-4.1G U3 were cut from SDS-PAGE, reduced, alkylated and in-gel digested 
with trypsin. The extracted peptides were analyzed on a matrix-assisted laser 
desorption/ionization mass spectrometer equipped with a time-of-flight analyzer 
(MALDI-TOF, Voyager STR Biospectrometry workstation, Applied System). The 
protein identities were obtained via a MS-Fit search against NCBI database using the 
mass fingerprints as query. 
 
10. In situ hybridization histochemistry 
The procedures have been described elsewhere previously (Liang et al, 2000; 
Zhang et al, 2005). Briefly, various 4.1G nucleotide fragments (listed in table 4) 
were subcloned into a pGEM-T easy vector and in vitro transcribed to 
digoxingenin-labeled cRNA probes to map the alternatively spliced 4.1G mRNA 
distribution in CNS. 
Free-floating rat brain and spinal cord sections were sequentially rinsed in 0.1M 
PB, 0.3% Triton-X-100, 1 μg/ml proteinase K, 4% PFA, and 0.75 glycine in 0.1M 
PB with slow agitation. After that, the sections were cleaned with 2×saline sodium 
citrate (SSC) buffer twice and preincubated with a hybrization buffer (2×SSC, 2% 
blocking reagent, 50% deionized formamide, and 0.1% N-lauroylsarcosine) omitted 
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probes for 1 hour at 60 °C to block potential non-specific probe-binding sites. The 
hybrization of sections with cRNA probes (800 ng/ml in the hybridization buffer) 
were performed overnight at 62 °C with gentle agitation.  
Following the hybridization, several washing steps were performed sequentially 
to minimize the non-specific cRNA probe binding, including washing with: 1) 50% 
deionized formamide and 0.1% N-lauroylsarcosine in 4×SSC buffer at 60°C; 2) 50% 
deionized formamide and 0.1% N-lauroylsarcosine in 2×SSC buffer at room 
temperature (RT) followed by at 60°C; 3) 0.1% N-lauroylsarcosine in 0.4×SSC 
buffer at room temperature (RT) and then at 60°C. 
To detect the hybridization signals, the sections were incubated with a sheep 
anti-digoxingenin antibody, which is linked with alkaline phosphatase (AP) in a 
TBS-blocking buffer (0.5% blocking reagent and 2% normal sheep serum in 0.1 M 
Tris-HCl buffered saline [TBS], pH 7.5) after being blocked with the same buffer 
omitted the antibody. After several washes with TBS plus 0.1% Tween-20, the 
sections were incubated with AP substrates, nitro-blue tetrazolium (NBT)/ 
5-bromo-4-chloro-3’-indolylphosphate (BCIP) to visualize the AP activity following 
a colorimetric reaction.  
In vitro transcription kit, blocking reagent, AP-conjugated antibody, and AP 
substrates were all obtained from Roche.  
 
11. Immunofluorescence labelling 
For immunofluorescence double labelling, fixed cells or free-floating rat brain 
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and spinal cord histological sections were washed for 30 minutes with three changes 
of PBS and incubated with PBS-T-NGS (0.3% Triton X-100 and 6% NGS in 0.1 M 
PBS) for 1 hour prior to the addition of primary antibodies to block potential 
nonspecific antibody binding sites. Primary antibodies were added together with 
PBS-T-NGS with proper dilutions for overnight incubation at RT. After 40 minutes 
washes with four changes of PBS, Alexa Fluor 488 or 568-conjugated secondary 
antibodies were incubated with the cells or sections for detecting the primary 
antibodies. Following rinse with PBS for three times, the cells or sections were 
routinely incubated with DAPI (0.2 μg/ml DAPI in PBS) to label the nuclei prior to 
be mounted and analyzed. To investigate the cellular expression of 4.1G in the CNS, 
anti-4.1G U1 or -4.1G U3 antibody was used in conjunction with 
anti-2',3'-Cyclic-nucleotide 3'-phosphodiesterase (CNP), -OX-42, 
-microtubule-associated protein 2 (MAP2), or glial fibrillary acidic protein (GFAP) 
to label oligodendrocytes, microglia, neurons, or astrocytes, respectively (Table 2-3).  
To investigate effects of 4.1G on tight junctions, the protocol was adapted from 
literature with minor modification (Fogg et al., 2005). Briefly, fixed confluent 
OLN-93 cells were permeablized with 1% SDS in PBS for 5 min,  washed with 
PBS, and preincubated with PBS-NGS (6% normal goat serum in PBS and) to block 
nonspecific binding. Primary antibodies were then added for overnight incubation at 
room temperature. Secondary antibodies conjugated with either Alexa Fluor 488 or 
568 were used for detecting the primary antibodies. Nuclei were visualized with 
DAPI. 
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12. Immunohistochemistry and transmission electron microscopy (TEM) 
Immunoperoxidase (Avidin-biotin complex method) were performed using a 
commercial ABC kit (Vectorlabs). Briefly, free-floating histological sections of rat 
CNS were rinsed for 30 minutes with 5 changes of PBS and pre-incubated with 
PBS-T-NGS for 1 hour to block non-specific binding. The sections were then 
incubated with primary antibody properly diluted in PBS-T-NGS at RT for an 
overnight period. After washes with PBS to eliminate excessive nonspecific binding 
of primary antibody, the sections were again incubated with a biotinylaed goat 
anti-rabbit IgG secondary antibody in PBS-T-NGS at RT for 80 minutes. The 
sections were carefully washed with PBS and allowed to bind with 
peroxidase-conjugated avidin-biotin complex (1:100 avidin and biotin in 0.1 M PB 
supplemented with 0.15% Triton-X-100 and 3% normal goat serum) for 80 minutes. 
After four washes with 0.05 M Tris buffer (TB) and one with 0.05% ammonium 
nickel sulfate [NH4Ni(SO4)2] in 0.05 M TB, the immunopositive signals were 
visualized following a colorimetric reaction, which was initiated by incubating the 
sections with 3’, 3’-diaminobenzedine (DAB)-HCl (0.05% DAB, 0.01% H2O2, and 
0.05% NH4Ni(SO4)2 in 0.05 M. The reaction was terminated by removing the DAB 
solution and washing the sections with 0.05 M TB, after satisfied strength of signals 
was achieved. The sections were mounted on the slides, completely dried, and 
dehydrated by passing through a series of ethanol of ascending concentrations and 
histoclear. After cover-slipping, the light microscopic analyses were carried out.  
For TEM study on the distribution of 4.1G in CNS, the immunopositive signals 
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were first obtained by performing aforementioned immunoperoxidase-based staining 
on brain sections, except for that Triton-X-100 was omitted throughout the whole 
experiment in order to preserve the ultrastructures. The stained sections were then 
cut into small pieces and post-fixed in osmium tetroxide (OsO4; 1%, pH7.4) at RT 
for 1 hour. Following that, the small pieces were dehydrated by passing through a 
series of ethanol of ascending concentration at RT (25% ethanol, 5 minutes; 50% 
ethanol, 10 minutes; 75% ethanol, 10 minutes; 95% ethanol, 10 minutes; 100% 
ethanol; and two changes of 100% acetone, 10 minutes). After dehydration, the 
sections were infiltrated sequentially with: 1) 100% acetone : resin (1 : 1) at RT for 
30 minutes; 2) 100% acetone : resin (1 : 6) at RT for an overnight period; 3) first 
change of fresh resin at RT for 20 minutes and then at 40 °C for 30 minutes; 4) 
second change of fresh resin at 45 °C for 1 hour; and 5) third change of fresh resin at 
50 °C for 1 hour. The small sections were finally embedded in fresh resin and 
allowed to polymerize at 60 °C for 24 hours. After that, ultrathin sections of 
approximate 100 nm thickness were prepared for TEM analyses.  
 
13. Antibodies 
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Table 2-3. List of antibodies used in the present study. 
Antibody (*) Host Supplier(#) Dilution 
   IB IHC/ICC 
Primary antibodies 
anti-4.1G U1 Rb (polyclonal) Inhouse 1:2,000 1:1,000 
anti-4.1G U3 Rb (polyclonal) Inhouse 1:3,000 1:2,000 
anti-β-actin (C-15) Ms (monoclonal) Sigma-Aldrich (A5441) - 1:3,000 
anti-CNP (11-5B) Ms (monoclonal) Millipore (MAB326R) - 1:500 
anti-Ezrin (3C12) Ms (monoclonal) Sigma-Aldrich (E8897) 1:2,000 1:1,000 
anti-FLAG-tag (M2) Ms (monoclonal) Sigma-Aldrich (F3165) - 1:2,000 
anti-GFAP (GA5) Ms (monoclonal) Millipore (MAB360) - 1:1,000 
anti-GFP Rb (polyclonal) Invitrogen (A11122) - 1:500 
Ms (monoclonal) Sigma-Aldrich (H3663) 1:2,000 1:1,000 
anti-HA-tag (HA-7) 
Rb (polyclonal) Millipore - 1:500 
anti-MAP2 (HM-2) Ms (monoclonal) Sigma-Aldrich (M9942) - 1:200 
anti-OX-42 (OX-42) Ms (monoclonal) Serotec (MCA275) - 1:50 
anti-pERM Rb (polyclonal) Cell Signaling (3141) - 1:500 
anti-ZO-1 Ms (monoclonal) Invitrogen (33-910) - 1:500 
Fluor-488/568 conjugated secondary antibodies 
anti-Ms IgG Gt Invitrogen (A11001) - 1:400 
anti-Rb IgG Gt Invitrogen (A11011) - 1:400 
Alkaline phosphatase conjugated secondary antibodies 
anti-Ms IgG Gt Millipore (AP124a) 1:5,000 - 
anti-Rb IgG Gt Millipore (AP132a) 1:8,000 - 
Biotinylated secondary antibodies 
anti-Ms IgG Gt Vectorlabs (BA-9200) - 1:200 
anti-Rb IgG Gt Vectorlabs (BA-1000) - 1:200 
*, clone number for the mouse monoclonal antibody; #, catalog number for the 
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14. Data Analyses 
All results were verified with at least two repeats of the experiments. 
Immunofluorescence and immunoelectron microscopic preparations were analyzed 
by using a laser scanning confocal microscope (Olympus Fluoview FV500, Olympus, 
Tokyo, Japan) and an electron microscope (Philips EM208S, FEI), respectively. 
Western blots were scanned with a GS-710 Calibrated Imaging Densitometer 
(Bio-Rad).  
For quantification of cell process arborization, OLN-93 cells were categorized 
as simple if they had one to three primary processes, as intermediate if more than 
three primary processes, and as complex if many secondary and tertiary processes 
from the primary branches (Li et al, 2007). For each cell culture preparation, at least 
5 discrete microscopic fields under 20× objective (20-40 transfected cells and 40-120 
untransfected cells per group) were analyzed. The results were expressed as the ratio 
of the number of cells in each complexity category over the number of cells counted. 
For quantification purposes, a cell was considered to be forming tight junctions if 
its ZO-1 labelling displayed a clear and sharp line of clustering at its border with at 
least two adjacent cells. For each cell culture preparation, at least 7 discrete 
microscopic fields under 20 × objective (10-60 transfectants per field, and > 150 
total cells) were analyzed. The results were expressed as the ratio of the number of 
cells forming tight junctions over the number of cells counted. Statistic analyses 
(Student’s t-test) were performed using Microsoft EXCEL program and difference is 
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RESULTS 
1.1 Cloning of 4.1G in rat CNS 
1.1.1 Generation of rat 4.1G gene contig 
Bioinformatic searches against National Center for Biotechnology Information 
(NCBI) nonredundant nucleotide database for rat 4.1G revealed two predicted rat 
4.1G mRNA, which were the reference sequences derived by automatic genome 
computation (GeneBank accession no: XM_001053351 and XM_220117). BLAST 
searches again NCBI expressed sequence tags (ESTs) from database for rat 4.1G 
transcripts uncovered a list of rat 4.1G cDNA clones. These EST sequences were 
assembled by using Vector NTI software package and a rat 4.1G gene contig was 
generated. Furthermore, during the process of assembling rat 4.1G gene contig, 
several alternatively splicing sites were discovered as being evident by the EST 
sequences. 
 
1.1.2. Amplification of 4.1G cDNA fragments in rat CNS 
 In order to examine 4.1G expressed in rat CNS, several PCR primer pairs were 
designed with reference to the assembled 4.1G gene contig (listed in Table 2-1). PCR 
amplifications were performed by using a commercially available rat hippocampal 
cDNA library or an inhouse produced cDNA reverse-transcribed from rat brain total 
RNA. All the clones were sequenced and analyzed (sequence data were not included 





Figure 3-1. Schematic representation of selected brain cDNAs cloned in the 
present study by using PCR technique. 
At the bottom, the black line with intermediate red label represents the Refseq 
(XM_001053351) and its ORF. In the rest part of the figure, solid black lines 
represent the cDNAs cloned and sequenced. Dashed black lines represent sequences 
being spliced. The green line represents an EST sequence deposited in NCBI database 
that contains sequence from 2006 to 2212. The red line with a dashed break represents 
the longest ORF derived from the cDNAs cloned in current study. The numbers 
indicate the position of nucleotides and the labels on the right indicate the primer pairs 
employed to clone the respective cDNAs. F1-F4 are the fragments used to generate 
cRNA probes for ISH. 
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The Reference 4.1G mRNA XM_001053351 was of 3855 nucleotides in length 
and included a deduced ORF from nucleotide residue 197 to 3184 (total length: 2988 
nucleotides). Our cloning experiments could amplify rat brain 4.1G cDNA sequence 
corresponding to the partial sequence of the reference ORF, i.e., from nucleotide 
residue 197 to 2005 and from 2213 to 3184, as assembled by cDNA clones amplified 
in several representative PCR experiments (Figure 3-1, PCR 1-6). The existence of 
rat 4.1G cDNA that included nucleotides residues from 2006 to 2212 (207 nucleotides 
in length) was evident by the EST sequence (GeneBank Accession: CO556949.1; 
Figure 3-1) deposited in NCBI EST database. Despite persistent efforts, we were 
unable to amplify this piece of cDNA sequence from rat brain cDNA libraries, might 
suggesting absence of the specific alternative splicing form of 4.1G in the CNS. 
Except for the above alternative splicing, other 4.1G alternative splicing variants were 
also discovered in rat brain cDNA. PCR with p7f and p8r amplifying the nucleotide 
sequence from residue 2274 to 3445 (residue number referred to XM_001053351) 
uncovered four distinctive 4.1G mRNA variants. The first one included the full 
sequence from residue 2274 to 3445, the second one lacked sequence from residue 
2304 to 2397 (94 nucleotides in length), the third one lacked sequence from residue 
2528 to 2776 (249 nucleotides in length), and the fourth one lacked sequence from 
residue 2528 to 2899 (372 nucleotides in length). Among these variants, the full 
length variant and the one lacking sequence from residue 2528 to 2899 have been 
reported previously (GeneBank Accession: CA512903.1, and GeneBank Accession: 
CB798576.1 , respectively). On the other hand, the two other cDNA sequences, the 
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one lacking sequence from residue 2304 to 2397 and the one lacking sequence from 
residue 3528 to 2899, probably represented previously unknown rat 4.1G mRNA 
alternative splicing variants. The question whether these two variants are 
brain-specific awaits further investigation.  
 
1.1.3. Analyses of pre-mRNA alternative splicing of 4.1G in CNS 
To further characterize the cDNA clones and different alternative variants as to 
how they were located on the rat 4.1G gene, bioinformatics were employed to analyze 
4.1G gene structure. First of all, 4.1G gene structure was compared among different 
species, including human, mouse and rat. Human 4.1G gene was located on 
chromosome 6 (6q23), spanning a total length of 223796 nucleotides (from 
131160487 to 131384462). The longest mRNA transcript (GeneBank Accession: 
NM_001431.3) was of 4475 nucleotide in length and consists of 20 exons. The start 
codon and stop codon were located on exon 2 and exon 19, respectively. Mouse 4.1G 
gene was located on chromosome 10 (10 A4) and span a total length of 71494 
nucleotides (from 25161393 to 25232886). Similarly, the mouse 4.1G mRNA 
transcript (GeneBank Accession: NM_013511.2) also consisted of 20 exons with a 
total length of 4271 nucleotides, and the start and stop codon were located on exon 2 
and exon 20, respectively. To investigate the gene structure of rat 4.1G as to how it is 
distributed on the rat genome, a BLAST search against the rat genome was performed 
using the aforementioned 4.1G reference mRNA sequence (XM-001053351) as a 
query. The result revealed that 4.1G gene was located on rat chromosome 1 (1p12) 
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and spanned a total length of 175910 nucleotides (from 20343833 to 20519742). 
Analyses of the BLAST results also revealed that the reference mRNA consisted of 20 
exons, and start codon and stop codon were located on exon 2 and exon 19. Careful 
comparison of the total number of exons, location of the start and stop codon, as well 
as the length of individual exon of human, mouse and rat 4.1G gene, suggested a 
highly conserved gene structure among the three species. 
To analyze the present alternative splicing variants of rat brain 4.1G, the cDNA 
clones were mapped to 4.1G gene structure. It was suggested that in rat CNS, 4.1G 
pre-mRNA alternatively splicing events predominantly occurred at exonal regions 
from exon 13 to exon 16 as show in Figure 3-2. The previously described variant 
(lacking sequence from residue 2006 to 2212), did not include exon 13 and 14. On the 
other hand, exon 15 and 16 of 4.1G were also subjected to alternative splicing in rat 
brain. The variants lacking sequence from 2304 to 2397 represented an alternative 
splicing pattern that excluded an middle portion of exon 15, the variant lacking 
sequence from 2528 to 2776 represented another pattern that excluded the 3’ end 
portion of exon 15, yet the one lacking sequence from 2528 to 2899 was another form 
that excluded the 3’ end portion of exon 15 and the whole exon 16. It was not clear 
why such a high frequency of alternative splicing occurred at exon 15. Intriguingly, 
exon 15 was unusually larger (562 nucleotides) than other exons, except for the last 
exon containing 3’-untranslated region (3’-UTR), might partially explain the reason 




Figure 3-2. Schematic representations of 4.1G cDNA structure and the structures 
of the alternative splicing variants. 
A. Exons of 4.1G gene as revealed by a BLAST search against rat genome by using 
XM_001053351 as a query. In the upper part, the black blocks represent the exons 
and the lines in between represents the introns. Note that the first intron is cut to give 
a better illustration because of its long length (~95.3 kb). B. CNS 4.1G splicing 
variant which does not include exon 13 and exon 14. C. CNS 4.1G alternative 














1.1.4. Analyses of the possible outcome of alternative splicing 
The reference mRNA (XM-001053351) bore a deduced ORF of 2898 nucleotides, 
encoding a protein of 966 amino acids. BLAST search against the NCBI Conserved 
Domain Database revealed characteristic 4.1 protein characteristic domains, an FERM 
domain, an SAB domain, and a CTD domain. These three domains were flanked by 
unique sequences (U1, U2 and U3) specific to 4.1G. Exclusion of exon 13 and 14 (207 
nucleotides in length) did not alter the reading frame, resulting a protein of 927 amino 
acids in length. Coincidently, the exon 13 and exon 14 seemingly encoded amino acid 
sequence corresponding to the SAB domain. Exclusion of the sequence from 2528 to 
2776 (249 nucleotides), and from 2528 to 2899 (372 nucleotides) also preserved the 
reading frame, whereas exclusion of sequence from 2304 to 2397 (94 nucleotides) 
resulted in an upstream shift of the stop codon, from 3185-TAA-3187 to 
2454-TGA-2456. These four directly cloned variants provided evidence for at least 
four different 4.1G isoforms. If there was combination of these different splicing 
patterns, there will theoretically result more isoforms. The potential longest brain 
4.1G isoform was the one only excluding exon 13 and 14 and contained 927 amino 
acids. The DNA sequence encoding this particular isoform was subcloned into pEGFP 
and pXJ-40 mammalian expression vectors for the subsequent functional analyses in 
cultured OLN93 cells as it was the major isoform expressed in this cell line 






1.2. Distribution of 4.1G mRNA in the CNS 
As described in the previous section, the present cloning experiments identified 
extensive alternative splicing events in 4.1G U3 region. We were curious about the 
impact of such a highly intense alternative splicing regulation pattern. In order to 
elaborate the significance of such a gene expression regulation pattern, we decided to 
decipher the distribution of different 4.1G mRNAs first. Digoxingenin-labeled cRNA 
probes were generated by using a sequence corresponding to the splicing regions, one 
upstream of the splicing regions and another two downstream of the splicing regions 
as templates (F1, F2, F3 and F4 in Figure 3-1). Comparative in situ hybridization 
histochemistry experiments were carried out to investigate the mRNA distribution of 
different alternative splicing variants in adult rat CNS (Fig 3-3, -4, -5 and -6). 
4.1G mRNA fragment F1 positive signals were found to be widely distributed 
throughout CNS regions, including not only the grey matters but also the white 
matters (Fig 3-3 A-D). This 4.1G mRNA fragment was most prominently expressed in 
the spinal cord (Fig 3-3I), followed by in cerebral and cerebellar cortices (Fig 3-3 G 
and H), and hippocampal formation (Fig 3-3I). Signals were also detected in the 
caudate and putamen (Fig 3-3F) and corpus callosum. Relatively sparse positive 
signals were detectable in the thalamus and brain stem. The ISH-positive cells are 
generally glia-like, typically small and dispersed. However, in the ventral horn of the 
spinal grey matter, a group of ISH-positive cell bodies are apparently larger than 
elsewhere, most likely to be the motor neurons. 
Compared to the ISH positive signals against the F1 fragment, the signals against 
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F2 fragment were seemingly lower in strength (Fig 3-4 A-D). In terms of the 
distribution of positive signals, in most CNS regions, the staining pattern was similar. 
The signal strength was strongest in spinal cord (Fig 3-4 J) and hippocampal 
formation (Fig 3-4 E), followed by in cerebral and cerebellar cortices (Fig 3-4 F and 
I), corpus callosum (Fig 3-4 H), and caudate and putamen (Fig 3-4 G). Similarly, the 
cell bodies of positive signals were small and uniform in appearance, although in the 
spinal cord and cerebellar grey matter, some cells appeared more variable and 
possibly with proximal expression of this mRNA fragment. However, in the spinal 
cord grey matter, the ISH positive signals were not detected with large cell bodies as 
shown in the ISH of F1 fragment (Fig 3-3 I and Fig 3-4 J).  
ISH staining of CNS sections with cRNA probes generated using F3 or F4 as the 
template showed almost the same signal pattern (Fig 3-5 and -6), which was also 
quite in accordance with the ISH staining of mRNA fragment of F1 except for a low 
signal strength. The glia-like positive cell bodies were scattered throughout the CNS 
regions, with most prominent localization in spinal cord (Fig 3-5 J and Fig 3-6 J). 
These positive cells appeared in hippocampal formation, corpus callosum, caudate 





Figure 3-3. Distribution of 4.1G mRNAs including F1 fragment. 
A-D. Photomicrographs showing the distribution of ISH signals in forebrain (A), 
midbrain (B), cerebellum (C), and spinal cord (D). E-I. Photomicrographs with high 
magnification showing the distribution of ISH signals in hippocampal formation (E), 
Caudate and Putamen (F), neocortex (G), cerebellar cortex (H) and spinal cord (I). I, 
II, III, cerebral cortex layer I, II and III; CA1, 2, 3, region I, II and III of hippocampus 
proper; cc, corpus callosum; CPu, Caudate and Putamen; Cbll, cerebellum; DG, 
dentate gyrus; GM, grey matter; HC, hippocampal formation; Pir, piriform cortex; 
Spc, transverse spinal cord; WM, white matter. Scale bars: 800 μm in A-D; 200 μm in 










Figure 3-4. Distribution of 4.1G mRNAs including F2 fragment. 
A-D. Photomicrographs showing the distribution of ISH signals in forebrain (A), 
midbrain (B), cerebellum (C), and spinal cord (D). E-J. Photomicrographs with high 
magnification showing the distribution of ISH signals in hippocampal formation (E), 
neocortex (F), Caudate and Putamen (G), corpus callosum (H), cerebellar cortex (I) 
and spinal cord (J). CA1, 2, 3, region I, II and III of hippocampus proper; cc, corpus 
callosum; CPu, Caudate and Putamen; DG, dentate gyrus; GM, grey matter; Spc, 
transverse spinal cord ; WM, white matter. Scale bars: 800 μm in A-D; 200 μm in E-I; 












Figure 3-5. Distribution of 4.1G mRNAs including F3 fragment. 
A-D. Photomicrographs showing the distribution of ISH signals in forebrain (A), 
midbrain (B), cerebellum (C), and spinal cord (D). E-J. Photomicrographs with high 
magnification showing the distribution of ISH signals in hippocampal formation (E), 
neocortex (F), Caudate and Putamen (G), corpus callosum (H), cerebellar cortex (I) 
and spinal cord (J). CA1, 2, 3, region I, II and III of hippocampus proper; cbll, 
cerebellum; cc, corpus callosum; CPu, Caudate and Putamen. DG, dentate gyrus; HC, 
hippocampal formation; GM, grey matter; Spc, transverse spinal cord; Thal, thalamus; 









Figure 3-6. Distribution of 4.1G mRNAs including F4 fragment. 
A-D. Photomicrographs showing the distribution of ISH signals in forebrain (A), 
midbrain (B), cerebellum (C), and spinal cord (D). E-J. Photomicrographs with high 
magnification showing the distribution of ISH signals in hippocampal formation (E), 
neocortex (F), Caudate and Putamen (G), corpus callosum (H), cerebellar cortex (I) 
and spinal cord (J). CA1, 2, 3, region I, II and III of hippocampus proper; Cbll, 
cerebellum cc, corpus callosum; CPu, Caudate and Putamen; DG, dentate gyrus; GM, 
grey matter; HC, hippocampal formation; Spc, transverse spinal cord; Thal, thalamus; 







1.3. 4.1G protein in the CNS 
As described in the above sections, pre-mRNA alternative splicing events were 
identified to regulate the expression of 4.1G in the CNS and differential expressions 
of some alternative spliced mRNAs in different CNS cell types were also detected by 
ISH. To further identify 4.1G protein isoforms in CNS and map their cellular and 
subcellular distribution in CNS, rabbit anti-4.1G polyclonal antibodies were raised. 
PCR results showed that cDNA sequences encoding the 4.1G U1 regions were 
conserved among different splicing isoforms, whereas cDNA sequences encoding the 
4.1G U3 region represented several alternative splicing sites. In addition, ISH results 
suggested that alternative splicing events may help regulate cell-type specific 
expression of different isoforms. Therefore, we decided to raise antibodies against 
these two regions, i.e. the U1 and U3 regions.  
Analyses of the primary amino acid sequence of one of the longest brain 4.1G 
isoform which includes both the U1 and U3 regions revealed that amino acid residues 
from 11 to 77 in U1 region and amino acid residues from 630 to 705 in U3 region 
bore high antigenecity. These two regions (termed as U1 and U3 hereafter) were 
in-frame subcloned into a pET41a vector and transformed the Escherichia coli BL21 
(DE3) strain. Thereafter, GST-U1 and GST-U3 fusion proteins were expressed in 
BL21 (DE3) bacteria with addition of IPTG and subsequently purified for 
immunizing rabbits and antibody purification (Fig 3-7A). 
The specificity of each antibody was confirmed by Western blotting of both 
OLN-93-overexpressed HA-4.1G and endogenous 4.1G from lysate of adult rat brain. 
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On the blot of cell lysate, both the U1 and U3 antibodies recognized a ~180 kDa band 
(lane 2 and 5, Fig. 3-7B), which was of the same apparent size as that recognized by a 
monoclonal antibody against HA-tag (lane 1, Fig. 3-7B). On the other hand, on the 
blot of brain lysate, both antibodies visualized 5 protein bands of about 180, 130, 110, 
90 and 80 kDa, respectively, although the 90 kDa band appeared much thicker on blot 
by anti-U1 antibody (lane 3 and 6, Fig. 3-7B). The fact that preincubation with their 
respective antigen peptides blocked visualization of all these 5 bands by both the U1 
and U3 antibodies suggested that both antibodies were specific to 4.1G and adequate 
to be used for subsequent investigation (lane 4 and 7, Fig. 3-7B). 
 
1   2   3   4   5   6   7 
Figure 3-7. In vitro expression of U1 and U3 antigen and in vitro and in vivo 
expression of 4.1G isoforms.  
A. Protein bands showing the in vitro expressed GST-U1 and GST-U3 antigen that 
were used to immunize NZW rabbits, and to affinity purify the 4.1G antibodies. The 
proteins were electroblotted onto PVDF membrane and visualized by Ponceau S red 
staining. Arrowheads indicate the antigen protein band. U1: GST-U1; U3: GST-U3. B. 
Western blots, showing the endogenous 4.1G in rat brain and HA-tagged 4.1G 
overexpressed in OLN-93 cells. Protein samples resolved on SDS-PAGE were either 
from HA-4.1G overexpressed OLN-93 cell lysate (lane 1, 2, and 5) or adult rat brain 
lysate (lane 3, 4, 6, and 7). The primary antibodies used for immunoblotting (IB) 
detection were an anti-HA tag antibody (lane 1), the anti-U1 antibody with (+, lane 4) 
or without (-, lane 2 and 3) addition of GST-4.1G U1, and the anti-U3 antibody with 





In addition to the Western blotting, an immunoprecipitation with anti-U3 
antibody was also performed to investigate the 4.1G isoforms expressed in rat brain. 
Comparisons between the immunoprecipitants by U3 antibody or control 
unimmunized rabbit IgG revealed that three distinct proteins were specifically 
precipitated by U3 antibody (Fig 3-8).  
 
Figure 3-8. Identify 4.1G isoforms expressed in brain. 
Adult rat brain lysate was subjected to immunoprecipitation (IP) using the anti-U3 
antibody or normal rabbit IgG. The immunopricipitants were resolved on SDS-PAGE 
and visualized using silver staining. The three protein bands indicated by asterisk (*) 
were subjected to MOLTI-TOF/MS analyses. 
 
The subsequent mass spectrometry analyses found that all three proteins generate 
peptides that could map to the predicted rat 4.1G protein sequence (Accession NO: 
XP_001053351.2) deposited in NCBI protein database (Table 3.1). As compared to 
 85
RESULTS 
the western blot in figure 3.7, the 180 kDa isoform corresponds to the present cloned 
and used 4.1G (927 aa), i.e. XP_001053351.2 minus aa sequence from 605 to 673. 
Since exclusion of nucleotide sequence from 2304 to 2397 resulted in a shift of frame, 
the generated isoform should not include peptides such as 
IVITGDAALDHDQALAQAIR and VTEGTIREEQEYEEELEEEPGQGAK. 
Therefore, none of the three isoforms corresponds to the variant without sequence 
from 2304 to 2397. Exclusion of sequence from 2528 to 2776 (249 nucleotides) and 
from 2528 to 2899 (372 nucleotides) do not change the frame and resulted in two 
isoforms of 844 aa (XP_001053351.2 minus aa sequence from 605 to 673, and from 
778 to 861) and 803 aa (XP_001053351.2 minus aa sequence from 605 to 673, and 
from 778 to 902) in length. Furthermore, the peptides translated from the excluded 
sequences do not match any peptides resulted from mass spectrometry. The calculated 
difference of the two isoforms is around 5 kDa. Based on the above analyses, it is 
likely that the 135 kDa and the 130 kDa isoforms corresponds to the isoforms 
generated from exclusion of sequence from 2528 to 2776 and 2528 to 2899. The exact 
match between the 4.1G protein isoforms appeared on SDS-PAGE and the alternative 
splicing variants calls for further investigation. 
Taken the Western blotting and immunoprecipitation results together, it was 
suggested that there might be at least 6 distinct 4.1G protein isoforms expressed in the 
CNS. These isoforms most probably correspond to the aforementioned predicted 4.1G 
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Note: * The residue numbers refer to XP_001053351.2, 4.1G (predicted); 
     ? The exact match between the protein isoforms and the splicing variants is not 
established so far. See text for detailed explanation and possible speculations. 





1.4. High level of 4.1G expression in the CNS 
 
Figure 3-9. Expression of 4.1G isoforms in multiple tissues and organs.  
A and B. Western blots showing the expression 4.1G isoforms in adult rat brain, heart, 
liver, spleen, kidney, testis and lung, as probed by anti-U1 (A), or anti-U3 (B) 
antibody. C. Western blot of β-actin serves as a loading control.  
 
After examining the molecular features of 4.1G expressed in rat CNS, the 
expression level of 4.1G protein was compared among various tissues. Protein lysate 
from brain, heart, liver, spleen, kidney, testis and lung of adult Wister rats were 
subjected to Western blotting analyses by using both anti-U1 and U3 antibodies. 
As shown in figure 3-9, 4.1G was most prominently expressed in testis. High 
level of 4.1G protein expression was also detected in brain and lung, while in heart, 
liver and spleen, 4.1G protein expression level was relatively lower. Interestingly, 
despite its wide expression among tissues, no detectable 4.1G protein was found in 
the kidney. Besides the difference in expression level among different tissues, the 
expression profile of different 4.1G isoforms among tissues was also varied. In brain, 
the 130 kDa and 90 kDa isoforms were most prominently expressed, while in testis 
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and lung, the 180 kDa and 90 kDa variants were the major 4.1G isoforms expressed. 
On the other hand, in heart, liver, and spleen, 4.1G mainly expressed as the 180 kDa 
isoform as shown on the Western blot. The differential expression profile of 4.1G 
isoforms among different tissue suggested diverse functions of 4.1G in different 
tissues. 
 
1.5. Postnatal expression of 4.1G isoforms increases along development 
To investigate the expression of 4.1G in different postnatal developmental stages 
of rat CNS, the CNS protein lysate of Wistar rats aged at 0, 3, 7, 10, 14, 21, 28 and 60 
postnatal days were subjected to Western blotting analyses by using both U1 and U3 
antibody.  
As shown in figure 3-10, except for the 180 kDa isoform, clear and visible 
expression of other 4.1G isoforms began to emerge at postnatal day (PD) 7 and 
increased along the course of postnatal development. High level of 4.1G expression 
started from PD21 and reached the peak at PD28. There was not much difference 
between the 4.1G expression level in CNS of rat aged at PD28 and PD60. Unlike 
other isoforms, the 180 kDa 4.1G isoform was expressed throughout the postnatal 
development. However, the expression of 180 kDa isoform seemingly increased 
discontinuously along the development. The 180 kDa isoform expression maintained 
at a very low level until PD3, increased to an intermediate level and maintained until 




Figure 3-10. Expression of 4.1G isoforms in different brain developmental stages. 
A and B. Western blots showing the expression 4.1G isoforms in postnatal day 0, 3, 7, 
10, 14, 21, 28 and adult rat brain, as probed by anti-U1 (A), or anti-U3 (B) antibody. 
C. Western blot of β-actin serves as a loading control. PD: postnatal day. 
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1.6. Cellular and subcellular localization of 4.1G protein in CNS 
1.6.1. Immunohistochemistry 
IHC with the in-house anti-U3 antibody revealed mostly cellular processes and 
relatively small cell bodies throughout the CNS (Fig. 3-11). In cerebrum cortex and 
hippocampus CA3 region, the immunoreactivity of anti-U3 antibody was abundant 
and generally appeared on cellular process and cells with small cell body (Fig. 3-11 A 
and B). In corpus callosum and cross section of cervical spinal cord, cellular 
processes with anti-U3 immunoreactivity were along the axon bundles (Fig. 3-11 C 
and D). In cerebellar cortex, the immunoreactivity prominently appeared in the 
granule and Purkinje cell layers. In the molecule layer, however, only some scattered 
cells and the related processes showed anti-U3 immunoreactivity (Fig 3-11 E and F). 
IHC with in-house anti-U1 antibody revealed a similar cellular distribution of 
4.1G to that revealed with in-house anti-U3 antibody (Fig. 3-12). However, additional 
signals were detected by U1 antibody, but not by U3 antibody. In the cerebral cortex, 
some axons of external pyramidal neurons showed immunoreactive signals (Fig. 3-12 
B). In the spinal cord gray matter, some motor neurons also showed immunoreactivity 




Figure 3-11. 4.1G expression in CNS, as revealed by IHC with U3 antibody. 
Immunoreactivity was detected in cerebral cortex (A), hippocampus CA3 region (B), 
corpus callosum (C), cervical spinal cord (D), and cerebellar cortex (E and F). CC, 
corpus callosum; Mol, molecular layer of cerebellar cortex; Pur, Purkinje cell layer of 
cerebellar cortex; GM, gray matter; WM, white matter. Scale bar: 20μm in A-D and F; 




Figure 3-12. 4.1G expression in CNS, as revealed by IHC with U1 antibody. 
Immunoreactivity was detected in cerebral cortex (A and B), corpus callosum (C), 
cerebellar cortex (D) and cervical spinal cord (E and F). CC, corpus callosum; Mol, 
molecular layer of cerebellar cortex; Pur, Purkinje cell layer of cerebellar cortex; GM, 




1.6.2. Immunofluorescence double labelling 
Double immunofluorescence study found that 4.1G-positive immunoreactivities 
(as probed by both anti-U1 and anti-U3 antibodies) were detected in microglia and 
some oligodendrocytes (Fig. 3-13 to Fig 3-16).  
 
Figure 3-13. Expression of 4.1G in oligodendrocytes as revealed by U1 antibody.  
Fluorescence confocal micrographs showing colocalization of 4.1G and CNP in 
cerebellar cortex section (A-C), transverse cervical spinal cord section (D-F), and 
longitudinal cervical spinal cord section (G-I). Arrowhead indicated the 
oligodendroglial cell bodies positive for both 4.1G and CNP. Scale bar: 40 μm in A-C; 




In cerebellar cortex, 4.1G U1 immunoreactivities were profoundly detected 
along the CNP (a well established oligodendrocyte marker)-positive oligodendroglial 
processes. Besides, some oligodendroglial cell bodies positive in both 4.1G and CNP 
were also found (as indicated by arrowhead, Fig 3-13 A-C). In the cervical spinal cord 
white matter, cell bodies with obvious double labelling of 4.1G and CNP were 
detected, further indicating expression of 4.1G in some oligodendrocytes (Fig 3-13 
D-I). It is intriguing to find that in the spinal longitudinal section, the 4.1G 
oligodendrocyte cell bodies seemingly queued up in lines along 4.1G and CNP 
positive axon bundles (Fig 3-13 G-I).  
 
 
Figure 3-14. Expression of 4.1G in microglia as revealed by U1 antibody.  
Fluorescence confocal micrographs showing colocalization of 4.1G and OX-42 in 
cerebellar cortex section (A-C), transverse cervical spinal cord section (D-F). 
Arrowhead indicated the microglia cell bodies positive for both 4.1G and OX-42. 




Figure 3-15. Expression of 4.1G in oligodendrocytes as revealed by U3 antibody.  
Fluorescence confocal micrographs showing colocalization of 4.1G and CNP in 
cerebellar cortex section (A-C), transverse cervical spinal cord section (D-F), and 
longitudinal cervical spinal cord section (G-I). Arrowhead indicated the 
oligodendroglial cell bodies positive for both 4.1G and CNP. Scale bar: 40 μm in A-C; 
20 μm in D-I. 
 
Colocalization between 4.1G and OX-42, a microglia marker in CNS, was also 
detected in cerebellar cortex and spinal cord white matter stained with anti-U1 and 
anti-OX-42 antibodies (Fig. 3-14). In the molecular layer of the cerebellar cortex, 
clear double labelling of 4.1G and OX-42 was detected in scattered microglia with 
ramified morphology (Fig 3-14 A-C). It should be noted that both cell bodies and 
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processes of microglia were positively stained by U1 antibody. In the cervical spinal 
cord white matter, ramified microglia were also stained positive for 4.1G U1 antibody 
in both cell bodies and processes (Fig 3-14 D-F).  
Despite the difference in probing various 4.1G protein isoforms in brain, 4.1G 
U3 antibody generated a very similar staining pattern to that generated by 4.1G U1 
antibody, i.e., U3 antibody also detecting 4.1G expression in oligodendrocytes and 
microglia (Fig 3-15 and -16). 
 
Figure 3-16. Expression of 4.1G in microglia as revealed by U3 antibody.  
Fluorescence confocal micrographs showing colocalization of 4.1G and OX-42 in 
cerebellar cortex section (A-C), transverse cervical spinal cord section (D-F). 
Arrowhead indicated the microglia cell bodies positive for both 4.1G and OX-42. 
Scale bar: 40 μm in A-C; 20 μm in D-F. 
 
On the other hand, in most of the CNS regions being examined, 4.1G-positve 
immunoreactivities (both U1 and U3) did not overlap those of GFAP, nor MAP2. 
Figure 3-17 shows typical 4.1G (U1 or U3) and GFAP (or MAP2) double 
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immunofluorescence staining pattern in the cerebellar cortex. As compared to the in 
situ hybridization results, it is interesting to see that, in mRNA level, 4.1G variants 
were expressed in spinal cord motor neuron, however, not in the protein level. The 
detailed reason for this discrepancy is not known yet.  
 
Figure 3-17. No expression of 4.1G in astrocytes and neurons.  
Fluorescence confocal micrographs showing the double staining of 4.1G U1 and 
GFAP (A), 4.1G U1 and MAP2 (B), 4.1G U3 and GFAP (C), and 4.1G U3 and MAP2 
(D) in the cerebellar cortex. Note that there are no obvious colocalization between 






1.6.3. Immunoelectron microscopy 
Immunoelectron microscopy detected the presence of 4.1G the microglia, which 
possess typical irregular shaped nucleus with a peripheral margination of 
heterochromatin, by using both the anti-4.1G U1 antibody and anti-4.1G U3 antibody. 
In microglia, 4.1G positive immunoreactivity was mainly concentrated in the 
perinuclear cytoplasm, although some signals were also detected in the processes (Fig. 
3-18 B and H). This observation agree with the previously described 
immunofluorescence labelling results, suggesting there might be important functional 
roles of 4.1G in microglia and most likely to be related to microglia membrane 
activities, such as sensing the pathological change and phagocytosis.  
Strong signals were also detected in a subgroup of oligodendrocytes. 4.1G 
positive signals were observed both in the perinuclear cytoplasm (Fig. 3-18 A and G), 
and in the processes that occupied the interstitial spaces between the axons (Fig. 3-18 
C and D). It was also observed that substantial amount of 4.1G immunoreactivity 
were in the oligodendrocyte processes closely associated with the inner and outer 
mesaxons of the myelinated axons (Fig. 3-18 D, F, K and L). Localization of 4.1G 
positive signals in paranodal and perinodal area also demonstrated (Fig. 3-18 E, F and 
K). These observations might imply important roles of 4.1G in controlling/ regulating 
myelination process. However, in some oligodendrocytes, there were no obvious 
detectable signals, suggesting that 4.1G was expressed in special group of 
oligodendrocyte (Fig. 3-18 C and J). 
In the CNS sections being observed, there were no obvious 4.1G 





Figure 3-18. Subcellular localization of 4.1G.  
The 4.1G positive immunoprecipitates were detected with anti-4.1G U3 antibody 
(A-F) or anti-4.1G U1 antibody (G-L). 4.1G Immunoreactivity was detected in 
microglia (B and H), a subgroup of oligodendrocyte (A, D and G), the perinodes (E 
and K), the processes associated with inner and outer mesaxons (D, F and L), as well 
as the oligodendrocyte processes in the interstitial spaces between axons (C and D). In 
the sections observed, no obvious 4.1G immunoreactivity was detected in neurons (C 
and I) and some subtype of oligodendrocytes (C and J). BV, blood vessel; MG, 
microglia; N, neuron;OL, oligodendrocyte; a, axon; n, node of Ranvier; pn, paranode. 










4.1G PROMOTES CELLULAR ARBORIZATION AND 




2.1. 4.1G expressed in OLN-93 cells 
In OLN-93 cells, 4.1G was expressed mainly as a single isoform of which the 
apparent size on SDS-PAGE was 180 kDa (Lane 0, Fig 3-19A).This 4.1G isoform are 
most likely to be the one cloned in the present study as 1) they were of the same 
apparent size, 180 kDa (Lane 0, Fig 3-19A and Lane 1 Fig 3-19B); 2) the 
overexpressed 4.1G and endogenous 4.1G in OLN-93 cell lysate migrated to the same 
position and were superposed on SDS-PAGE (Lane 1, Fig 3-19A). Furthermore, the 
OLN-93 cell expressed 4.1G isoform was probably corresponding to the 180 kDa 
4.1G isoform detected in the brain lysate.  
As the immunoblotting results showed a discrepancy between the predicted 
molecular weight of 4.1G (102.6 kDa) and the actual migration of 4.1G (177.2 kDa) 
on SDS-PAGE, the migration rate of different 4.1G fragments was tested. It was 
found that HA-4.1GΔN, 4.1GΔC, and 4.1GΔNC all showed different extent of 
difference between the predicted and actual molecular weights with HA-4.1GΔC 
showing the highest difference as 49.6% and HA-4.1GΔNC the lowest difference as 
41.8% (Fig 3-19 B). The results may suggest that 1) the higher the predicted 
molecular weight was, the higher the migration discrepancy was; and 2) the 




Figure 3-19. Expression of 4.1G and its truncated proteins in OLN-93 cells. 
A. Western blot, testing the difference between the calculated molecular weights and 
actual migration on SDS-PAGE of endogenous 4.1G or overexpressed HA-tagged 
4.1G and truncated proteins in OLN-93 cells. Samples subjected to Western blotting 
analyses were lysate of untransfected OLN-93 cells (lane 0), and HA-4.1G (lane 1), 
HA-4.1GΔN (lane 2), HA-4.1GΔC (lane 3) or HA-4.1GΔNC (lane 4) overexpressed 
OLN-93 cells. The primary antibody used for immunoblotting detection was anti-U3 
antibody. The arrow head indicates the endogenous 4.1G and arrows indicate 
truncated 4.1G. Note that HA-tagged 4.1G migrates at almost the same position as the 
endogenous 4.1G in lane 2. B. Western blot, confirming the actual migration of 
overexpressed HA-tagged 4.1G (lane 1), 4.1G ΔN (lane 2), 4.1G ΔC (lane 3), and 
4.1G ΔNC (lane 4) on SDS-PAGE. The primary antibody used for immunoblotting 
detection was anti-HA antibody. Arrows indicate HA-tagged 4.1G or truncated 4.1G. 
 
2.2. 4.1G promotes arborization of cultured OLN-93 cells 
To explore possible functional roles of 4.1G, we overexpressed HA-tagged 4.1G, 
N-terminal FERM domain-deleted 4.1GΔN, C-terminal domain deleted 4.1GΔC, 
FERM- and CTD- double deleted 4.1GΔNC, or an unrelated FLAG-tagged JN141 
(Zhang et al, 2005) as a negative control in OLN-93 cells (Fig. 3-20). Under normal 
culture conditions, a majority of the OLN-93 cells displayed bipolar morphology at 
low to medium density, although a few cells had more than two primary processes. 
The surface of the cell bodies and processes was generally smooth.  
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At 48 h after the transfection, the overexpressed proteins were mainly found in 
the cytoplasm of host cells. OLN-93 cells overexpressing HA-tagged 4.1G or 4.1GΔC 
exhibited more numerous primary processes in comparison with the neighboring 
untransfected cells. Moreover, large amount of significantly finer processes with 
many prickles extended from the primary processes or directly from the cell bodies. 
Enrichment of HA-4.1G or 4.1GΔC at the end of fine processes was also observed 
(Fig. 3-20 A and B). OLN-93 cells overexpressing HA-4.1GΔN, ΔNC and 
FLAG-JN141, however, did not display clear morphological changes in arborization 
(Fig. 3-20 C-E). Statistical analyses showed significantly higher percentage of 
complex morphology of cells transfected with HA-4.1G [58.7%±18.7% (mean±SD; 
n=24) versus 7.9%±6.1% (n=66) of neighboring untransfected cells] or HA-4.1GΔC 
[55.3%±14.1 (n=20) versus 9.4%±7.8% (n=81)] than in cells transfected with 
HA-4.1GΔN [3.3%±7.5% (n=38) versus 3.6%±4.9% (n=122)], HA-4.1GΔNC 
[6.4%±8.1% (n=31) versus 2.2%±2.8% (n=121)], or FLAG-JN141 [0 (n=20) versus 
4.2±8.3% (n=41)], and lower percentage of simple morphology in cells transfected 
with HA-4.1G (18.3%±29.1 versus 72.9%±7.6%) or HA-4.1GΔC (30.7%±24.3% 
versus 73.1%±9.4%) than in cells transfected with HA-4.1ΔN (81.1%±17.8% versus 
82.2%±3.0%), HA-4.1GΔNC (79.9%±14.5% versus 88.8%±4.8%), or FLAG-JN141 
(81.6%±12.8% versus 82.6%±11.3%). The percentages of cells with intermediate 
process arbor complexity were not significantly different among the groups (Fig. 3-20 
F). Together these results suggested that 4.1G promoted arborization of OLN-93 cells 
under low culture densities, and the FERM domain-containing N-terminus was 
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essential for the realization of this effect. 
 
 
Figure 3-20. Effects of 4.1G on OLN-93 arborization.  
A-E. Photomicrographs showing OLN-93 cells overexpressing HA-tagged 4.1G (A), 
4.1GΔC (B), 4.1GΔN (C), 4.1GΔNC (D), or FLAG-tagged JN141 (E). In each upper 
panel, red stained for 4.1G (A-E), green stained for HA (A-D) or FLAG (E) and blue 
stained for nuclei by DAPI. The lower panels show the phase-contrast images of the 
same fields. Arrows indicate fluorescence labeling of the endogenous 4.1G. The 
schematic diagram on top of each panel represents the overexpressed protein. Scale 
bars: 40 μm. F. Quantification of effects of overexpressed HA-4.1G, truncated 4.1Gs, 
or FLAG-tagged JN141 on OLN-93 cells arborization (* P<0.05, unpaired Student’s 
t-test；Compared with cells overexpressing 4.1GΔN, 4.1GΔNC, JN141, and with 




2.3. 4.1G colocolizes with the tight junction protein ZO-1 
In the course of surveying the functional roles of 4.1G in OLN-93 cells, it was 
found that, in low- to medium-density cell culture conditions, overexpessed 4.1G 
protein concentrated at the sites where the processes of adjacent OLN-93 cell made 
contacts (Fig. 3-21). Subsequent rodamine-conjugated phalloidin staining revealed a 
colocalization of overexpressed 4.1G with F-actin (Fig. 3-21 A-C). As F-actin plays 
pivotal structural and supportive roles during the formation of cell junctions, it was 
intriguing to investigate whether 4.1G was involved in such cellular interactions. It 
was found that, when the cells made contacts, overexpressed 4.1G was recruited to 
the points of contact as was the tight junction protein ZO-1 (Fig. 3-21 D-F).  
 
Figure 3-21. Double immunofluorescence labelling of the transiently expressed 
4.1G and F-actin or tight junction protein ZO-1. 
A-C. At medium culturing density, GFP-tagged 4.1G (A) and F-actin (B) both 
concentrated at the points where the processes of adjacent OLN-93 cells contacted 
each other. D-F. At the same condition, colocalization of HA-tagged 4.1G (D) and 
ZO-1(E) at the cell-cell contacts was also observed. Yellow indicates the 





We further investigated the localization of endogenous 4.1G in OLN-93 cells 
along the course of formation of cell-cell contacts. In subconfluent OLN-93 cells, 
endogenous 4.1G expression was very low, if at all, as evident by the mostly 
undetectable level of immunofluorescent staining with the anti-U3 antibody (Fig. 
3-20). However, in the confluent OLN-93 cells, a substantial amount of 4.1G 
appeared at the cell-cell contacts, and the immunofluorescent staining from multiple 
cells in the field displayed a honeycomb-like pattern. Double immunofluorescent 
staining of 4.1G together with ZO-1 (a well-established and widely used tight 
junction marker) strongly suggested colocalization of the two at cell-cell junctions 
(Fig. 3-22 A-C). The transverse scanning of the monolayer of OLN-93 also showed 
a colocalization of 4.1G with ZO-1. 
 
Figure 3-22. Immunofluorescence of 4.1G and tight junction protein ZO-1 in 
confluent OLN-93 cells. 
4.1G (A) and ZO-1 (B) localized at the cell-cell contacts in a continuous pattern and 
C shows the superimposition of A and B. The upper panels are the two dimensional 
images and the lower panels are the transverse sections of cells constructed by 
3-dimensional remodeling of a series of sequentially taken laser confocal images. 
The yellow color in C indicates the colocalization of 4.1G and ZO-1 at tight junction. 
Scale bar: 10 μm.  
 
2.4. 4.1G is indispensible for tight junction formation in confluent OLN-93 cells 
To test if 4.1G regulated tight junction formation, siRNAs were purchased to 
specifically knockdown 4.1G in OLN-93 cells. A silencing efficiency of over 70% 
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was achieved by using the commercially available 4.1G siRNAs, as estimated on 
Western blot (Fig. 3-23D). In confluent OLN-93 cells treated with a negative control 
siRNA, which lacked significant homology to any mammalian gene sequences, tight 
junction assembly was not affected. Both 4.1G and ZO-1 mostly localized at the cell 
borders and barely in the cytoplasm. The immunofluorescence staining pattern of 
4.1G and ZO-1 were typically honeycomb-like (Fig. 3-23 E and F). In cells treated 
with the 4.1G siRNA, however, ZO-1 was diffused in the cytoplasm and barely 
present at the cell-cell contacts, suggesting failed tight junction formation. 
Interestingly, even in the culture treated with 4.1G siRNA there were patches of cells 
where 4.1G was not effectively silenced, and where with no exception tight junction 
formation also seemingly proceeded as normal (Fig. 3-23 A and B). Similar 
confluency of the cell cultures with either control siRNA or 4.1G siRNA group was 
verified by the comparable DAPI staining of the two (Fig. 3-23 A and E). Inhibition 
of tight junction assembly by silencing 4.1G further supported the notion that 4.1G 




Figure 3-23. Effects of 4.1G silencing on tight junction formation in confluent 
OLN-93 cells. 
A-C. Micrographs, showing fluorescence labelling of 4.1G and DAPI (A), ZO-1 (B), 
and Ezrin and DAPI (C) in OLN-93 cells treated with a 4.1G siRNA. White boxes 
highlight areas where 4.1G is ineffectively silenced. D. Western blots, illustrating the 
knockdown efficiency of 4.1G siRNA (upper) or Ezrin siRNA (middle). Western blot 
of β-actin (lower) served as a loading control. Ctrl: lysate from OLN-93 cells treated 
with control siRNA; Expt: lysate from OLN-93 cells treated with 4.1G or Ezrin 
siRNA. Open and solid arrowheads indicate 250 and 150 kDa positions respectively, 
and open and solid arrows indicate 100 and 75 kDa positions respectively. E-L. 
Micrographs, showing the fluorescence labelling of 4.1G and DAPI (E and I), ZO-1 
(F and J), ezrin and DAPI (G and K), and pERM and DAPI (H and L) in OLN-93 
cells treated with a control siRNA (E-H), or an Ezrin siRNA (I-L). Scale bar: 50 μm. 
 
To further verify that the inhibition of tight junction formation was specifically 
due to the silencing of 4.1G protein expression, we also silenced the expression of 
ezrin, another member of 4.1G protein superfamily. The silencing efficiency of ezrin 
siRNA was verified to be more than 70% by Western blotting (Fig. 3-23D). In the 
confluent OLN-93 cells treated with the control siRNA, a substantial amount of 
ezrin was phosphorylated and recruited to the plasma membrane (Fig. 3-23 G and 
H). After transfection with the Ezrin siRNA, both cytoplasmic and membrane 
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portion of ezrin decreased dramatically, however, the assembly of tight junctions as 
judged by the accumulation of ZO-1 immunoreactivity at the borders among the 
OLN-93 cells seemed not affected (Fig. 3-23 J, K and L). Furthermore, it was not 
observed that silencing 4.1G would affect ezrin expression and localization or vice 
versa (Fig. 3-23 C and I). This further suggested that 4.1G specifically regulate tight 
junction formation in confluent OLN-93 cells, whereas ezrin probably played no 
significant role in this regard.  
 
2.5. FERM domain is essential for 4.1G recruitment to and assembly of tight 
junctions 
To characterize the effects of 4.1G at molecular levels, HA-tagged 4.1G and its 
truncated mutants were overexpressed in OLN-93 cells. The cells were allowed to 
grow confluent and continued culturing for another 5 days. As shown in figure 3-24, 
HA-tagged 4.1G and 4.1GΔC were recruited to the tight junctions and were almost 
absent from the cytoplasm (Fig. 3-24 A-C and D-F). The state of confluency and 
formation of tight junctions of the cultured OLN-93 cells were evident by the 
localization of tight junction marker protein, ZO-1, at the cell-cell contacts as a 
honeycomb-like pattern (Fig. 3-24 B, E, H, and K). However, HA-tagged 4.1GΔN 
and 4.1GΔNC, which lacked the N-terminal FERM domain, were not efficiently 
recruited to the tight junctions and retained the cytoplasmic distribution (Fig. 3-24 
G-I and J-L). The seemingly normal formation of tight junction in some of the 
4.1GΔN and 4.1GΔNC transfectants was probably due to the action of endogenous 
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4.1G of OLN-93 cells. These results implied that 4.1G, directly or indirectly, 
interacted with one or more tight junction proteins, and was incorporated into the 
tight junction complex of confluent OLN-93 cells. The FERM domain, but not the 
other parts of the protein, was indispensable and sufficient for the interaction and 
recruitment.
 
Figure 3-24. 4.1G FERM domain is essential for proper recruitment of 4.1G to 
the tight junctions in OLN-93 cells. 
HA-tagged 4.1G (A-C), 4.1G ΔC (D-F), 4.1G ΔN (G-I), and 4.1G ΔNC (J-L) were 
transiently overexpressed in OLN-93 cells. HA-tagged 4.1G (A) and 4.1GΔC (D) 
were recruited to the cell-cell contacts, but not HA-tagged 4.1GΔN (G) and 
4.1GΔNC (J). For each fusion protein, green stained for HA-tag in the upper panels 
(A, D, G, and J), red stained for ZO-1 in the middle panel (B, E, H, and K) and the 
superimposition of upper and middle panels were shown in the lower panels (C, F, I, 
and L). The yellow color in C and F indicates the recruitment of HA-tagged 4.1G (C) 





To further elucidate the role of 4.1G in the establishment of tight junctions, 
calcium-switch experiments were carried out. OLN-93 cells transiently 
overexpressing GFP-tagged 4.1G or truncated 4.1G proteins were subjected to a 
calcium switch protocol in order to elicit disassembly and subsequent 
re-establishment of tight junctions. The course of these processes was then 
monitored under a fluorescence microscope. It has been well documented that 
decreasing or withdrawing the calcium cations in culture medium disrupts the cell 
polarity and cell junctions. Overt disruption of cell junctions after 4-hour exposure 
of confluent OLN-93 to calcium-free medium was evident by diffused ZO-1 
immunofluorescence staining, despite the overexpression of 4.1G or its different 
truncation mutants in the cells (Fig. 3-25 A, E, I, and M). This indicated that 4.1G 
did not prevent the disruption of tight junctions upon calcium withdrawal. However, 
4 hours after switching back to the normal culture medium, GFP-tagged 4.1G or 
4.1GΔC-transfected OLN-93 cells showed obviously more reassembly of tight 
junctions compared with the neighboring untransfected OLN-93 cells, as evident by 
the relocation of ZO-1 to the cell-cell contacts in these transfected cells (Fig. 3-25 
B-D and F-H). Although the ZO-1 and 4.1G staining patterns were not as perfectly 
honeycomb-like as those before the calcium withdrawal, they did show the trend of 
moving toward the cell periphery and assembling at the cell-cell contacts, in contrast 
to cells overexpressing GFP-tagged 4.1GΔN or 4.1GΔNC that were not much 
different in ZO-1 immunostaining pattern from the neighboring untransfected cells 
(Fig. 3-25 J-L and N-P). The latter cells showed a much delayed reassembly of tight 
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junctions in comparison with cells overexpressing GFP-tagged 4.1G or 4.1GΔC. 
Statistical analyses showed significantly higher percentage of visible tight junction 
formation in cells transfected with 4.1G [20.0±11.7% cells (mean±SD, n=278) 
versus 1.7±0.8% (n=1859) in neighboring untransfected cells] or 4.1GΔC 
[14.5±9.5% (n=189) versus 3.0±1.5% (n=1424)] than in cells transfected with 
4.1GΔN [3.2±2.3% (n=371) versus 2.4±0.7% (n=1539)] or 4.1GΔNC [5.6±5.3% 
(n=361) versus 4.5±3.3% (n=1718)] (Fig. 3-25Q). Together, these results attest from 
another perspective that 4.1G positively regulated tight junction formation and the 
FERM domain-containing N-terminus was essential for this functional role of 4.1G. 
In view of the facts that, 1) there are no conserved domains or motifs in 4.1G U1 
region as revealed by BLAST searches against PROSITE and NCBI conserved 
domain database; 2) no previously reported functional roles of 4.1 family proteins 
are attributed to the U1 regions, it is reasonable to assign functional roles of 4.1G 




Figure 3-25. Effects of overexpressed 4.1G on reassembly of tight junctions in 
calcium-switch-experienced OLN-93 cells.  
A-P. When confluent OLN-93 cells with well established tight junctions were 
exposed to calcium free solution for 4 h, tight junctions were completely disrupted 
(A, E, I, and M). Four hours after switching back to the normal medium, GFP-4.1G 
(B-D) and GFP-4.1G ΔC (F-H) transfectants showed more advanced reassembly of 
tight junction than the neighboring untransfected cells, while GFP-4.1G ΔN (J-L) 
and GFP-4.1G ΔNC (N-P) transfectants did not display obvious differences as 
compared to neighboring untransfected cells. Green stained for GFP, red stained for 
ZO-1 and blue stained for nuclei by DAPI. Scale bar: 20 μm. Q. Quantification of 
effects of overexpressed GFP-tagged 4.1G and truncated proteins on reassembly of 












1. Regulation of 4.1G expression by pre-mRNA alternative splicing 
One of the major findings of the present project is that there is an impressive 
repertoire of 4.1G isoforms resulted from pre-mRNA alternative splicing in the CNS. 
These splicing events include a constitutive splicing of exon 13 and 14, as well as 4 
alternative splicing of exon 15 and exon 16. As suggested by Western blotting and 
immunoprecipitation and subsequent mass spectrometry, there might be at least 6 
major 4.1G protein isoforms in CNS. Although previous reports suggested more than 
one 4.1G isoforms in CNS, the primary structures of the splicing variants are not 
annotated (Ohno et al, 2005; Ohno et al, 2006). This present study provides the first 
comprehensive characterization of the alternative splicing events of 4.1G occurring 
in CNS. However, the present study is not able to match the different alternative 
splicing variants to the protein bands appearing on Western blots and 
immunoprecipitation exactly. 
It is striking to find that exon 13 and 14 are constitutively absent from CNS 
4.1G repertoire, as these two exons are required to encode a fully functional 
spectrin-actin binding domain, which is rather conserved and important to 4.1 
protein as a cytoskeleton-membrane cross-linker. It is intriguing to note that, among 
characterized 4.1G isoforms to date, only the present CNS 4.1G and adrenal gland 
4.1G are found to be devoid of SAB domain (Wang et al, 2010). However, exclusion 
of exons encoding SAB domain is not unusual among other 4.1 proteins. In 
well-hemoglobinized erytheroblast, a minor isoform (2% occurrence) was found to 
lack the exons encoding SAB domain (Tan et al, 2005). In a study on the domain 
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evolution and RNA processing among protein 4.1 paralogues, Parra et al (2004) 
found that in all non-muscle tissue, exons encoding for 4.1B SAB domain were 
subjected to alternative splicing. In the same report, the authors suggested that the 
exons encode the conserved SAB domain and CTD domain exhibited tissue-specific 
alternative splicing. In line with this statement, current findings demonstrated 
absence of 4.1G SAB domain in the CNS. Interestingly, Drosophila protein 4.1 
homolog, coracle, does not contain SAB domain and plays important roles in septate 
junction (Baumgartner et al, 1996). Therefore, it is tempting to hypothesize that 
protein 4.1 SAB domain is a relatively recent adaptation during evolution and the 
CNS 4.1G, which lacks the SAB domain, might represent some isoforms that 
structurally and/or functionally resemble their ancestor. 
It also should be noted that exon 15 (a, b, c and d) and 16 (corresponding to the 
U3 regions) of 4.1G also displayed great complexity, i.e. extensive alternative 
splicing occurred at this region. This complexity directly resulted in a great number 
of 4.1G isoforms, which appeared as a complex protein expression pattern in the 
immunoblots. Theoretically, the combinatorial alternative splicing of exon 13, 14, 
15a, 15b, 15c, 15d and 16 would result in an incredibly large number of 4.1G 
isoforms, although actually some isoforms are so rare that they are not detected by 
PCR or immunoblotting. This notion was supported by the investigation of protein 
4.1 cDNAs actually expressed in single cell types. In these surveys, it was found that 
although only several major protein 4.1 isoforms was found in some representative 
cell types, many rare isoforms could also expressed in these cells (Parra et al, 2004). 
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This great versatility in the cDNA structure is not unique to 4.1G, but a shared 
feature among all mammalian 4.1 proteins, as a comparable or even greater 
complexity was also found in the U3 region among other protein 4.1 paralogues. 
However, it should be noted that, despite their homology to 4.1 proteins, ERM 
proteins possess much less alternative splicing isoforms. It is not known exactly why 
4.1 proteins displayed such a magnificent pattern of complexity in cDNA structure. 
A reasonable explanation is that these many isoforms are evolutional products to 
serve different functions in various tissues and cells. As suggested in our 
multiple-tissue western blots, 4.1G isoforms expressed in different tissues varies 
immensely.  
 
2. A broad distribution of 4.1G isoforms among CNS cell types 
To date, the literature reports on 4.1G expression in the CNS are inconsistent 
and even contradictory with each other. For example, Ohno et al (2005) 
demonstrated by using immunofluorescence double labelling that in adult rat and 
mice brain, 4.1G was exclusively expressed by microglia, but not neurons and other 
glial cells. However, the expression of 4.1G protein in cultured neurons and 4.1G 
mRNA in isolated oligodendrocytes are also reported, challenging the statement 
given by Ohno et al (Lu et al, 2004a; Lu et al, 2004b). The ambiguity in the 
distribution of 4.1G protein in CNS could be due to 1) the many 4.1G isoforms 
might not be confined to a single cell type, but distributed among CNS cells; 2) 




In the present study, two inhouse antibodies detected 4.1G in both the processes 
and the cell bodies of microglia in the adult rat brain. It agrees with previous finding 
by Ohno et al (2005) that 4.1G was expressed in rodent microglia. Besides, present 
results also demonstrated for the first time that 4.1G protein might also expressed by 
oligodendrocytes in vivo. However, it should be noted that the present 
immunofluorescence double labelling with inhouse antibodies demonstrated only a 
partial colocalization of 4.1G with oligodendrocyte marker, CNP, suggesting that 
4.1G is not expressed in all oligodendrocytes. In line with this result, current EM 
study also revealed that some oligodendrocytes expressed 4.1G whereas some others 
did not. The reason for this heterogeneity is not investigated so far. It is possible that 
4.1G defines subsets of oligodendrocytes in the adult rat CNS. It has been 
demonstrated on the level of electron microscope that three different types of 
oligodendrocytes, with light, medium, and dark cytoplasm respectively, existed in 
adult wistar rat brain. In addition, a decrease in the number of oligodendrocytes with 
light cytoplasm and an increase in the number of those with dark cytoplasm were 
also observed as the rat grew older (Wawrzyniak-Gacek A, 2002). A quantitative EM 
study to establish the link between the 4.1G immunoreactivity and microscopic 
appearance of oligodendrocytes will provide a more explicit answer to whether 
current 4.1G-positive oligodendrocytes belongs to any of these three types. 
Furthermore, the present ISH and ABC staining also revealed the expression of 4.1G 
in a selected group of neuron in the spinal cord.  
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Besides the broad distribution of 4.1G protein in CNS cells, ISH results suggest 
an isoform specific 4.1G distribution among neurons and glia. When F2 was used as 
template to generate anti-sense probe for 4.1G detection, the ISH signals are 
confined to the glial cells. In contrast, when F1 was used, ISH signals are detected in 
both glial cells and neurons. It should be noted that F2 is located in the U3 regions 
(mainly in exon 15c and exon 16) where extensive alternative splicing occurs. It is 
suggested that those 4.1G isoforms expressed in neurons lacks exon 15c and/or exon 
16. Therefore, if F2 was used as the anti-sense probe, it could bind to these isoforms 
and generated no signals in neurons. On the other hand, since F1 contains the 
sequence of the common regions (continuously expressed exons), they can bind to 
both the glial and neuron specific isoforms. However, due to the antibodies used 
could detect most major 4.1G isoforms, the current study did not differentiate the 
isoforms expressed in microglia and in oligodendrocytes. It would be an interesting 
topic to study the cell type-specific 4.1G isoforms and their functions in the future.  
 
3. 4.1G as a tight junction protein 
Despite a diverging range of protein architectures, FERM-domain containing 
proteins play important roles in morphogenesis of both invertebrates and vertebrates 
by regulating the membrane polarization and cytoskeleton organization (Tepass, 
2009). 4.1 family proteins are commonly involved in the molecular specification and 
membrane organization during membrane polarization. In epithelial cells, both 4.1R 
and 4.1B were implied in the specification of membrane polarity, although the 
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mechanism might appear different. While 4.1R directly interacts with ZO-1 and 
ZO-2 and helps maintain the tight junction structural integrity in confluent MDCK 
cells, a Golgi-associated 4.1B isoform is reportedly involved in proper membrane 
targeting of several proteins belonging to polarized membrane subdomains, such as 
ZO-1 and ZO-2 to the apical tight junction and Na+/K+ ATPase to the bilateral 
membrane in human bronchial epithelial (HBE) cells (Mattagajasingh et al, 2000; 
Kang et al, 2009a). Furthermore, in Drosophila, a 4.1 family homologue, Coracle, 
colocalized with Neuroxin IV at septate junction, which was conventionally thought 
to be the invertebrate analog of tight junction (Baumgartner et al, 1996; Ward et al, 
1998). These results might suggest an evolutionarily conserved role of 4.1 family 
proteins in regulating intercellular junction assembly. The present study 
demonstrates for the first time that 4.1G is a tight junction protein and indispensable 
for tight junction formation in OLN-93 cells. Although tight junctions are mainly 
reported in epithelial cells, both tight junction proteins and tight junction-like 
structures have become more and more recognized in myelinating oligodendrocytes 
of the CNS and Schwann cells of the PNS (Spiegel and Peles, 2002). The present 
results support those previous findings, and further establish a possible role of 4.1G 
in the formation of cell junctions in the CNS. 
The proper assembly of functional tight junctions is a multi-step process, 
probably initiated with establishment of cell-cell adhesion mediated by cadherin and 
nectin at the contact site of adjacent cells to form primordial junctions where 
components of both tight junction and adherens junction are recruited to, and 
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eventually assembled into mature tight junctions and adherens junctions with distinct 
junctional apparatus (Matter and Balda, 2003; Green et al, 2010). The present results 
demonstrated the initial enrichment of 4.1G at the cell-cell contact sites, as well as 
the requirement of 4.1G for the clustering of the tight junction protein ZO-1 at the 
cell-cell contacts. It is conceivable to hypothesize that, at the early contacts, 4.1G 
might be involved in cell-cell adhesion, since colocalization of 4.1G and E-cadherin, 
as well as the association between 4.1G and CADM1, have been evident in mouse 
testis (Terada et al, 2005; Terada et al, 2010). It is further supported by colocalization 
of 4.1G and F-actin at the initial cell-cell contact site, as localization of F-actin to the 
cell-cell adhesion site after junction initiation has been reported (Adams et al, 1996; 
Adams et al, 1998). The present study did not address the possibility of 4.1G 
involvement in the formation of adherens junctions. Based on the detection of 4.1R 
in both tight junctions and adherens junctions (Mattagajasingh et al, 2000; Yang et al, 
2009), it is tempting to suggest similarly multifarious functions of 4.1G in the CNS 
and PNS, and the roles of 4.1G in the formation of adherens junctions and possibly 
other types of junctions still await future investigations. 
 
4. 4.1G FERM domain in tight junction assembly 
Although current knockdown experiments showed the essentiality of 4.1G in 
tight junction assembly, further elucidation is required to decipher the functional 
significance of 4.1G in different stages (such as early initiation vs later specification) 
of tight junction formation. The maturation of functional tight junctions requires an 
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orchestrated incorporation of transmembrane tight junction proteins including 
occludin, claudins and junctional adhesion molecules (JAMs), and peripheral 
membrane proteins such as ZOs (Denker and Nigam, 1998; Stevenson and Keon, 
1998; Shin et al, 2006b). This process is precisely guided by signals conveyed from 
two evolutionarily conserved polarity complexes. One of them consists crumbs3 
(CRB3), protein associated with Lin seven 1 (PALS1) and PALS1-associated tight 
junction protein (PATJ), while the other one includes partition defective 3 (Par3), 
Par6, and atypical protein kinase C (aPKC) (Shin et al, 2006).  
Using the 4.1G antibodies, we attempted co-immunoprecipitation, but could not show a 
direct interaction between 4.1G and ZO-1, or 4.1G and the oligodendrocyte specific tight 
junction integral membrane protein OSP/claudin 11 (Morita et al, 1999) under the current 
experimental condition. This seems not particularly surprising for tight junction proteins. It 
has been shown, for example, that despite the lack of direct interaction with ZO-1 and JAM, 
PATJ colocalizes with ZO-1 and regulates tight junction formation through its interaction 
with Crumbs and ZO-3 (Lemmers et al 2002; Roh et al 2002). Thus, the effects of 4.1G on 
tight junction might be mediated through its interaction with other tight junction molecules 
or the interaction between 4.1G and ZO-1 or OSP/claudin11 is indirect. A definite answer to 
this question awaits future investigations. 
In the present study, we illustrated that the effect of 4.1G on tight junction 
formation seems dependent on the FERM domain, as 1) FERM domain-truncated 
4.1G proteins, i.e. 4.1GΔN or 4.1GΔNC were not recruited to the tight junction in 
confluent OLN-93 cells; 2) these domain-deleted proteins lacked the ability to 
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promote tight junction formation in confluent OLN-93 cells in a calcium switch 
experiment. As the FERM domain is well documented for its membrane association 
ability (Diakowski et al, 2006), it would be speculated that 4.1G FERM domain 
helped anchor tight junction components to their proper membrane locations. This 
notion is not without preceding evidence. In a study of CRB3 regulated tight 
junction formation in MCF10A cells, mutations of a putative FERM binding motif of 
CRB3 led to severe malformation of tight junctions (Fogg et al, 2005). However, the 
FERM proteins that interact with CRB3 remain unclear. EPB41L5, a protein 4.1 
homologue, was reported to directly interact with crumbs proteins through the 
conserved FERM domain and negatively regulate the function of crumbs complex in 
tight junction formation (Jensen and Westerfield, 2004; Hsu et al, 2006; Gosens et al, 
2007). Provided FERM domain is capable of binding crumbs, 4.1G might associate 
with crumbs-related polarity complex and facilitate the proper membrane positioning 
of the complex. Depletion of 4.1G before this stage probably results in an inability of 
mobilizing the tight junction proteins to the correct membrane domain and 
eventually failed tight junction assembly. Together, the present findings stress the 
importance of FERM domain in 4.1G-regulated tight junction formation in OLN-93 
cells and possibly in the CNS in vivo, although a direct interaction between 4.1G 
FERM and crumbs requires future substantiation.  
 
5. 4.1G, cellular arborization and oligodendrocyte differentiation 
In the developmental CNS, during the developmental progression from 
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oligodendrocyte precursor cells (OPCs) to oligodendrocytes (OLs), the cells of OL 
lineage exhibit dramatic changes as manifested by morphologically extending more 
numerous cell processes and genotypically beginning the expression of a group of 
OL-specific genes. The morphological differentiation during oligodendrogenesis is 
often associated with remodeling of intracellular cytoskeleton networks (Baumann 
and Pham-Dinh, 2001). In accordance to this notion, various cytoskeleton-related 
proteins like CNP, juxtanodin and sirtuin 2 emerged along the course of OL 
differentiation, although the exact mechanisms how these proteins regulate tubulin 
and/or actin cytoskeleton organization may or may not have been fully understood 
(Li et al, 2007; Zhang et al, 2005; Lee et al, 2005). For instance, juxtanodin, an 
ERM-like oligodendrocyte-specific protein, was found to associate with F-actin 
stress fiber to inhibit its disassembly and promote cellular ramification in cultured 
OLN-93 cells (Zhang et al, 2005; Meng et al, 2010). 4.1G is very likely to also play 
an important role in OL differentiation, because 1) 4.1G was found to be highly 
upregulated during OPC to OL transition and specifically expressed in OLs(Dugas et 
al, 2006); and 2) the present study demonstrated that 4.1G overexpression induced 
extensive arborization of OLN-93 cells, whose antigenic properties resemble those 
of immature OLs (Richter-Landsberg and Heinrich, 1996). Given the fact that 4.1 
family proteins are capable of establishing links between plasma membrane and 
intracellular cytoskeleton, it awaits future studies to test if 4.1G is involved in 
re-organization of the cytoskeleton during OL differentiation and maintenance of the 




6. 4.1G, tight junction and CNS myelination 
In PNS, 4.1G was detected at paranodes, Schmidt-Lanterman incisures, and 
periaxonal, mesaxonal and abaxonal membranes of myelin internodes, implying a 
possible function of 4.1G in myelinating Schwann cells (Ohno et al, 2006). The 
similar distribution of several tight junction proteins, including MUPP1, PATJ1 and 
ZOs in PNS (Poliak et al, 2002), might suggest interactions between 4.1G and these 
junctional proteins. In CNS, immunoperoxidase-based transmission electron 
microscopic study in our lab also detected 4.1G at the CNS perinode, paranodal 
regions and the noncompact outmost layer of myelin sheath (data not shown). This 
strongly suggests a role of 4.1G in myelinating OLs in the CNS. One possibility is 
that 4.1G helps maintain the axo-glial interaction. 4.1B was found to localize at the 
internode, paranodal and juxtaparanodal regions of myelinating axons, anchor Caspr 
and Caspr2 to the axonal cytoskeleton and stabilize septate-like paranodal junctions 
in both PNS and CNS (Denisenko-Nehrbass et al, 2003; Horresh et al, 2010). It will 
be interesting to investigate whether 4.1G is involved in similar functions to stabilize 
the junctional complexes on the OL membrane side.  
 
Besides, other possible functions of 4.1G in myelination could also not be ruled 
out. Given 4.1G-dependent tight junction formation in cultured OLN-93 cells, it 
might imply an involvement of 4.1G in myelin architecture, as tight junction strands 
linking the adjacent membranes of myelinating cells were also demonstrated in CNS 
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myelin sheaths (Dermietzel, 1974; Dermietzel and Kroczek, 1980). Unlike the well 
established molecular architectures of tight junctions in PNS myelin sheath, tight 
junctions have been reported to be restricted in internode as particulate strands 
running parallel to the axis and radially through the myelin sheaths, and the only 
tight junction protein reported up to now in the CNS is OSP/claudin 11 (Morita et al, 
1999; Spiegel and Peles, 2002), which interestingly displays an upregulation and 
expression pattern similar to that of 4.1G in the aforementioned functional genomic 
analysis of OL differentiation (Dugas et al, 2006). Its absence in OSP/claudin 11-null 
mice resulted in the lacks of tight junction strands and a low action potential 
propagation speed in small axons (Devaux and Gow, 2008). Taken these findings 
together, it is worthwhile to further verify the functions of 4.1G in more elaborate 
models mimicking in vivo myelination. 
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1. Conclusions 
The following conclusions are drawn from the current study: 
1. Expression of 4.1G in CNS is regulated by pre-mRNA alternative splicing. CNS 
4.1G isoforms are devoid of spectrin-actin binding domain and display 
alternative splicing at the U3 regions; 
2. Distribution of 4.1G mRNA in the CNS shows a splicing variants-specific 
pattern; 
3. There might be at least six 4.1G protein isoforms expressed in CNS and their 
apparent molecular weight on SDS-PAGE ranges from ~80 kDa to ~180 kDa; 
4. CNS expresses high level of 4.1G isoforms and the postnatal expression level of 
4.1G isoforms increases along the developmental stages; 
5. 4.1G is expressed in microglia. A subgroup of oligodendrocytes and a selected 
group of neurons in spinal cord might also express 4.1G isoform(s). However, 
4.1G is not expressed in astrocytes; 
6. Overexpression of 4.1G promotes cellular arborization in OLN-93 cells and 
FERM domain is essential to this effect; 
7. 4.1G localizes to tight junctions and is indispensible to the formation of tight 
junction in confluent OLN-93 cells in culture; 
8. FERM domain is responsible for the recruitment of 4.1G to and 4.1G effect in 
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2. Future studies 
Despite the findings of 4.1G expression and function in this current study, the 
exploration of the roles of 4.1G in the CNS is still ongoing. The following studies 
could be conducted to further elucidate the physiology of 4.1G in CNS. 
1. The present study revealed a comprehensive alternative splicing pattern of 4.1G 
in CNS and demonstrated the expression of 4.1G in several CNS cells types. 
However, the exact distribution of 4.1G isoforms in CNS cell types is not fully 
illustrated. Therefore, development of isoform-specific antibody against 4.1G 
could further decipher the expression of 4.1G isoforms in CNS and facilitate the 
understanding of functional roles of 4.1G isoforms; 
2.  4.1G is demonstrated to promote cellular arborization and tight junction 
formation of OLN-93 cell, which is an oligodendroglial cell line. However, it 
does not clarify the molecular mechanism which induces such process outgrowth 
and junctional formation. It would be tempting to investigate the molecular 
interactions and regulations underlying this effect, as well as its implication in 
lineage progression and proper function of oligodendrocytes; 
3. Clinical investigation has revealed an altered 4.1G expression in patients with 
non-small cell lung cancer and ependymomas. As tight junction plays important 
roles in cancer proliferation and metastasis, investigation of functions of 4.1G in 
cancer cell proliferation and migration, as well as in the pathology of gliomas, 
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